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   Intermittent social defeat stress induces cross-sensitization to psychostimulants 
and escalation of drug self-administration. These behaviors could result from the stress-
induced neuroadaptation in the mesocorticolimbic dopamine circuit. Brain-derived 
neurotrophic factor (BDNF) in the ventral tegmental area (VTA) is persistently elevated 
after social defeat stress, and may contribute to the stress-induced neuroadaptation in the 
mesocorticolimbic dopamine circuit. BDNF modulates synaptic plasticity, and facilitates 
stress- and drug-induced neuroadaptations in the mesocorticolimbic system. The present 
research examined the role of mesolimbic BDNF signaling in social defeat stress-induced 
cross-sensitization to psychostimulants and the escalation of cocaine self-administration 
in rats. We measured drug taking behavior with the acquisition, progressive ratio, and 
binge paradigms during self-administration. With BDNF overexpression in the ventral 
tegmental area (VTA), single social defeat stress-induced cross-sensitization to 
amphetamine (AMPH) was significantly potentiated. VTA-BDNF overexpression also 
facilitates acquisition of cocaine self-administration, and a positive correlation between 
the level of VTA BDNF and drug intake during 12 hour binge was observed. We also 
found significant increase of DeltaFosB expression in the nucleus accumbens (NAc), the 
projection area of the VTA, in rats received intra-VTA BDNF overexpression. We 
therefore examined whether BDNF signaling in the NAc is important for social defeat 
stress-induced cross-sensitization by knockdown of the receptor of BDNF (neurotrophin 
tyrosine kinase receptor type 2, TrkB) there. NAc TrkB knockdown prevented social 
defeat stress-induced cross-sensitization to psychostimulant. Also social defeat stress-
induced increase of DeltaFosB in the NAc was prevented by TrkB knockdown. Several 
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other factors up-regulated by stress, such as the GluA1 subunit of Alpha-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and BDNF in the VTA 
were also prevented. We conclude that BDNF signaling in the VTA increases social 
defeat stress-induced vulnerability to psychostimulants, manifested as potentiated cross-
sensitization/sensitization to AMPH and escalation of cocaine self-administration. Also 
BDNF signaling in the NAc is necessary for the stress-induced neuroadaptation and 
behavioral sensitization to psychostimulants. Therefore, TrkB in the NAc could be a 
therapeutic target to prevent stress-induced vulnerability to drugs of abuse in the future. 
DeltaFosB in the NAc shell could be a neural substrate underlying persistent cross-
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Chapter 1  
INTRODUCTION AND BACKGROUND 
Overview of Addiction 
Epidemiology of addiction 
 Addiction is a chronic, often relapsing brain disease that causes compulsive drug 
seeking and intake, despite harmful consequences. The Diagnostic and Statistical Manual 
of Mental Disorders (DSM) IV defines psychostimulants (such as amphetamine and 
cocaine) abuse as the failure to fulfill major obligations, use despite physical hazard, 
recurrent legal problems, or recurrent social and interpersonal problems (American 
Psychiatric Association., 2000). Drug addiction is one of the top three public health 
concerns in the United States, and it is the most costly neuropsychiatric disorder (G. R. 
Uhl & Grow, 2004). Substance abuse and addiction have an economic impact of $524 
billion per year in the U.S, due to addiction related health care, loss of productivity, crime 
and drug enforcement (United Nations Office on Drugs and Crime, 2007 and Office of 
National Drug Control Policy, 2004). Based on World Drug Report (2007), the annual 
prevalence of illicit drug abuse is about 4.8% of the world population. The National 
Survey on Drug Use and Health (NSDUH) estimates that currently there are at least 20.4 
million drug abusers in the U.S, and 1.9 million among them are cocaine users, and the 
number is still increasing. Although tremendous resources have been devoted to cut down 
the consumption of addictive drugs, such efforts are unsuccessful in general. The crux of 
this problem is the lack of effective therapy to counter addiction’s powerful disruptive 
effects on human brain, due to the poor understanding on the neural mechanism of 
addiction. 
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Addictive drugs are taken initially to achieve the pleasant feeling or to alleviate 
the negative feelings caused by aversive life experience, but with repeated drug use, the 
brain reward system is usurped and changed by addictive drugs, and drugs become more 
important than other goals important for survival, and all activities are directed towards 
obtaining and consuming drugs (S. E. Hyman, Malenka, & Nestler, 2006). In according 
to DSM-IV, the diagnosis of substance dependence should be made in the presence of 
three or more of following behavioral manifestations: tolerance or increased amounts of 
the substance to achieve desired effect; withdrawal symptoms; persistent desire or 
unsuccessful efforts to control substance use; use of substances regardless of persistent 
physical or psychological problem and the reduction of social, occupational or 
recreational activities. Whereas the diagnostic criterion of substance abuse are as 
following: frequent use of substances in situation in which it is physically hazardous 
(such as driving); failure to fulfill major obligations at work, school, home due to 
substance use; continued use regardless of frequent social or interpersonal, or even legal 
problems (American Psychiatric Association., 2000). Such criteria of substance 
dependence and abuse apply to psychostimulants, although psychostimulants use does 
not lead to clinically significant withdrawal syndrome, as opiate drugs and alcohol 
(Miller, Summers, & Gold, 1993).   
As a pathological process, pathogenesis of addiction encompasses three stages: 1) 
substance abuse out of control regardless of adverse consequences; 2) development of the 
tolerance to the effect of the substance upon repeated exposure, leading to the 
requirement of larger doses to achieve the desired effect; and 3) physical and 
psychological symptoms of distress, discomfort, or impairment upon reduction or 
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cessation of substance use, which is also well-known as the “withdrawal syndrome”. The 
withdrawal syndrome is commonly found in abusers of non-psychostimulants, such as 
opiates, ethanol, nicotine and so on, but not obvious in abusers of psychostimulants, such 
as cocaine and amphetamine. The uncontrolled drug use regardless of aversive 
consequences and the persistent risk of relapse even after years of abstinence are the most 
harmful aspects of addiction. The current study is primarily focused on psychostimulant 
sensitization and compulsive abuse.    
Pharmacology of psychostimulants and pathological effects 
Psychostimulants, including amphetamine (AMPH) and cocaine, are highly 
addictive substances inducing psychomotor activation by direct increasing extra neuronal 
dopamine levels through different mechanisms.  
AMPH is one member of a group of compounds referred as amphetamines, 
including AMPH, methamphetamine and methylenedioxymethamphetamine. Due to its 
structural similarity with dopamine, AMPH is a substrate for the dopamine transporter 
(DAT). Extraneuronal AMPH binds with DAT and is transported into the cytosol. It 
competitively inhibits DA uptake. Due to its lipophilicity, when in high extraneuronal 
concentration, AMPH also can diffuse directly into the cells without the aid of DAT 
(Gulaboski et al., 2007). In the cytoplasm, AMPH increases the intracellular binding sites 
of DAT for dopamine and induces the reverse transport of dopamine mediated by DAT 
(Sulzer et al., 1995), through the exchange of extracellular amphetamine with 
intracellular dopamine (S. R. Jones, Joseph, Barak, Caron, & Wightman, 1999). 
Intracellular AMPH also interferes with the vesicular monoamine transporter 2 (VMAT-
2), impairs active transport of the monoamines into synaptic vesicles. Furthermore, 
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AMPH can diffuse into the vesicle and induces the release of vesicular dopamine to the 
cytosol (Sulzer, Sonders, Poulsen, & Galli, 2005), further increases the dopamine 
concentration in the cytosol. Cytosolic dopamine is then released to the extracellular 
space via reverse transport by the DAT, leading to an increase in extracellular dopamine. 
Ultimately, AMPH induced abnormal DA release can saturate DA receptors and 
eventually lead to depletion of intracellular DA stores (Schmitz, Lee, Schmauss, Gonon, 
& Sulzer, 2001).  
 Compared with the effects of AMPH, cocaine directly inhibits the DAT (J. M. Brown, 
Hanson, & Fleckenstein, 2001), prevents the reuptake of dopamine into the nerve 
terminals, resulting in increased levels of dopamine in the synaptic cleft. Although both 
AMPH and cocaine have effects on the monoamine transporters noradrenaline transporter 
and serotonin transporter (SERT) (Gatley, Gifford, Volkow, & Fowler, 1998), their 
reinforcing effects are largely dependent on their action on dopaminergic 
neurotransmission (M C Ritz & Kuhar, 1989; Mary C. Ritz, Lamb, Goldberg, & Kuhar, 
1987). It is important to note that the potency of cocaine on SERT is much higher than 
amphetamine (Han & Gu, 2006).  
Several neurological impairments are present in psychostimulants abusers. Some 
cocaine abusers suffer from seizures, epilepsy (Koppel, Samkoff, & Daras, 1996), 
cerebral ischaemia, cerebral hemorrhages, cerebral atrophy, cognitive impairment, and 
mood and movement disorders (Rodnitzky & Keyser, 1992). Clinical studies discovered 
that psychostimulant addicts exhibit a higher rate of occurrence of depressive disorders, 
attention deficit disorder, and other psychopathologies (Clure et al., 1999) than normal 
people. Furthermore, degraded performance on response inhibition tasks (Goldstein, 
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Volkow, Wang, Fowler, & Rajaram, 2001) and working memory tasks (Hester & 
Garavan, 2004) were found commonly in chronic abusers of psychostimulants, 
suggesting dysfunction in prefrontal cortex induced by chronic psychostimulants abuse. 
Brain imaging studies are consistent with the clinical data: decreased structural integrity 
in prefrontal white matter (Lim, Choi, Pomara, Wolkin, & Rotrosen, 2002) and gray 
matter density in frontal and temporal cortical regions (Franklin et al., 2002) were 
broadly found in chronic cocaine addicts.    
Besides the pathological effect on the central nervous system, chronic 
psychostimulants abuse also causes cardiovascular and respiratory complications. 
Cocaine increases the level of circulating catecholamines in the central nervous system, 
resulting in arterial vasoconstriction. Cocaine also increases myocardial oxygen demand, 
leading to myocardial ischemia, and tachycardia. Cocaine inhibits the reuptake of 
catecholamines at adrenergic nerve terminals in the peripheral cardiovascular system and 
inhibits baroreceptors, ultimately induces myocardial toxicity (Perper & Van Thiel, 
1992a). The cardiovascular complications associated with cocaine abuse range from 
episodic arrhythmias to myocardial infarction, strokes, and cardiomyopathy, which are 
very common and dangerous.  
Upper respiratory and pulmonary complications are also common in addicts who 
snort cocaine or smoke “crack”, ranging from ischemia, necrosis, infections of the nasal 
mucosa, pulmonary hemorrhages/barotrauma/infection, asthma, and persistent gas-
exchange abnormalities (Perper & Van Thiel, 1992b). If compulsive consumption of 
psychostimulants can be curbed, the consequent pathological complications and 
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impairment to nervous system would not take place. Thus the better understanding on the 
molecular mechanism underlying compulsive drug taking and craving is in urgent need.    
Hypothetical models for a mechanism of drug dependence 
Opponent processes theory 
Several theories have been raised trying to explain the mechanism of addiction. 
Opponent processes theory is a well-established psychological version of the 
pleasure/withdrawal view of addiction. Based on this theory, the pathogenesis of drug 
dependence is composed of an initial rewarding process and a following negative 
(opponent) process, and a negative process serves to restore the homeostasis and bring 
the drug stimulated brain rewarding system back to normal state. The subjective 
experience of drug taking is dependent on the summation of active process and the 
negative process, as depicted in Figure 1. Following the repeated drug use, the effect of 
active process remains unchanged but the negative process is strengthened and elongated, 
the manifestation will be the tolerance to drug euphoria and the unpleasant withdrawal 
syndrome.  
Koob and colleagues suggested the neural mechanism of opponent processes 
theory. In their theory, drug exposure activates mesolimbic dopamine circuitry, and 
increases dopamine neurotransmission in the NAc, which mediates the reinforcing effect 
of acute drug exposure. Upon repeated exposure to drug, tolerance will develop in the 
mesolimbic dopamine circuit. After the cessation of drug use, mesolimbic dopamine 
levels drop to the level below the baseline for a long-period of time therefore causing the 
negative effect during withdrawal. Escape from the negative withdrawal effect drives the 
compulsive drug taking/seeking behavior in addicts. This mechanism is also defined as 
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“negative reinforcement” in contrast to the “positive reinforcement” experienced during 
the initial stage of addiction. Repeated drug exposure also activates the HPA axis, 
resulting in an increase of corticosteroids and stress response, further exacerbating the 
negative state during drug withdrawal. However, withdrawal symptoms are maximal 
within several days after the cessation of drug use, but the drug craving and sensitization 
are persistent and can be further enhanced following long periods of drug abstinence (J. 
W. Grimm, Hope, Wise, & Shaham, 2001). Thus the opponent processes theory cannot 
sufficiently explain all the essential aspects addiction, especially the long-lasting 
characteristic of drug craving, sensitization and life-long risk of relapse after the negative 
process has decayed away.  
Incentive sensitization theory 
Because compulsive drug taking behavior and persistent craving cannot be fully 
explained by simple avoiding negative state during withdrawal, Robinson and Berridge 
raised the incentive-sensitization theory of addiction. This theory suggests that repeated 
drug exposure induces long-lasting neural sensitization in mesolimbic-related systems, 
which assigns excessive incentive salience toward drug and related cues, leading to 
compulsive drug seeking, intake and relapse (T. E. Robinson & Berridge, 1993, 2000). 
This theory also suggests the distinction between drug “liking” and “wanting”; sensitized 
brain reward circuits attribute incentive salience to reward-related stimuli and cause 
excessive “wanting” for the reward regardless of whether it is “liked” or not (Berridge & 
Robinson, 1998). When sensitized incentive salience is attributed to drug cues in addicts, 
it can trigger compulsive drug pursuit.  
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In human addiction studies, many researchers take subjective ‘high’ and euphoria 
as their primary dependent measures for sensitization; however, accumulating evidence 
suggests that drug-induced neural sensitization, such as sensitized DA transmission, is 
more closely related to incentive salience attributed to drug, rather than drug-induced 
euphoria. This is demonstrated most obvious from the observation that stimulant drug 
abusers develop a tolerance to the euphorigenic effects of the drug, but still show 
enhanced drug-seeking behavior (Pontieri, Mainero, La Riccia, Passarelli, & Orzi, 1995; 
Pontieri, Tanda, & Di Chiara, 1995). In other words, drugs of abuse sensitize neural 
mechanisms involved in incentive valence assigned to drug (wanting), rather than the 
drug-induced euphoria (liking).    
Psychostimulants-induced Sensitization  
Overview on sensitization 
Sensitization is defined as the augmented locomotor response to 
drug(psychomotor sensitization) and the potentiated incentive salience (incentive 
sensitization) attributed to drug or drug-related cues upon repeated drug exposure, a key 
process of addiction (T. E. Robinson & Berridge, 1993). Both psychomotor sensitization 
and incentive sensitization are mediated by sensitization of the mesocorticolimbic 
dopamine circuit (T. E. Robinson & Berridge, 1993). Neural sensitization in the 
mesocorticolimbic dopamine circuit encompasses neurotransmission strength changes on 
circuit-level, and neural physiological changes on neuronal level, which will be further 
discussed in the following chapters. A simplified illustration of effects of a variety of 
drugs of abuse, including psychostimulants on mesocorticolimbic circuit can be found in 
Figure 2.  
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Psychomotor sensitization is augmented behavioral response to drugs or drugs 
related cues, manifested in many types of behaviors response, such as locomotor activity, 
stereotypical head movements, arousal, and exploration. The manifestation of 
psychomotor sensitization is dependent on the dose of drug administered. For example, at 
moderate dose, psychostimulants primarily induced locomotor activity, but at a higher 
dose, qualitative changes took place in behavior, and motor stereotypies take place and 
compete with locomotion. The incentive sensitization is the excessive incentive salience 
attributed to drug and drug related cues, and manifested in compulsive drug 
taking/seeking behavior. Despite the widespread use of locomotor sensitization as the 
behavioral model to study the neuroadaptations underlying sensitization, cocaine self-
administration, which can measure reinforcing effect of drugs and the motivation to 
acquire drugs, has greater face validity as a model to study the neuroadaptation 
underlying the motivational changes during compulsive drug taking/seeking behaviors. 
It is important to note that treatment inducing psychomotor sensitization also 
facilitates subsequent drug taking behavior during cocaine self-administration with 
extended drug access (C. R. Ferrario & Robinson, 2007). Vice versa, extended access to 
cocaine during self-administration induces locomotor sensitization to cocaine one month 
after the cessation of self-administration (Carrie R. Ferrario et al., 2005). These data 
suggest that the neural changes mediating psychomotor sensitization are important for the 
transition from casual to compulsive drug use, and imply that incentive sensitization and 
psychomotor activation share some common neural substrates.  
There is also criticism about the validity of sensitization behavioral models based 
on the lack of evidence showing behavioral sensitization in humans. Indeed, several 
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studies have shown that behavioral and neural sensitization in humans in response to 
drugs of abuse (Di Chiara, 2002; Strakowski, Sax, Setters, & Keck, 1996), although in 
humans the demonstration of behavioral sensitization is not in the form of locomotor 
activity. Strakowski and colleagues found that repeated amphetamine (0.25mg/kg) 
injection induces sensitization in human subjects, demonstrated as enhanced 
activity/energy level, heart rate, amount of speech and eye-blink rates (Strakowski et al., 
1996). Therefore, these data suggest that behavior sensitization model in rodents is a 
valid model to study the neuroadaptation underlying repeated psychostimulants challenge 
in humans.     
Neural substrates and mechanism underlying sensitization 
The mesoaccumbens dopamine (DA) system is the primary neural substrate 
underlying the behavioral sensitization to psychostimulants. To further determine the site 
of action of drugs during the induction of sensitization, AMPH or morphine has been 
microinfused directly into the different regions of mesolimbic dopamine circuit, such as 
the VTA, where the dopamine neurons located, or the NAc, the terminal field of 
dopamine neurons. Repeated infusion of drugs into the NAc only induced acute 
locomotor response, but no sensitization observed upon repeated administration. In 
contrast, both psychostimulants and opioids induce sensitized response through actions in 
the VTA (Joyce & Iversen, 1979; Paul Vezina & Stewart, 1990), and animals received 
intra-VTA microinjection of AMPH exhibited behavioral sensitization to systemic 
AMPH injection (P W Kalivas & Weber, 1988). Thus VTA is required for the induction 
of behavioral sensitization to repeated psychostimulants. Whereas microinfusion of 
psychostimulant into the NAc can maintain the expression of sensitization, suggesting 
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that NAc is the region responsible for the expression of sensitization. To further 
characterize the mechanism of the action of dopamine in the VTA during the induction of 
sensitization, selective dopamine type 1 (D1) and type 2 (D2) receptor antagonists were 
microinfused into the VTA. Intra-VTA infusion of D1 receptor, but not D2 receptor 
antagonist can prevent repeated AMPH or morphine injection induced sensitization 
(Stewart & Vezina, 1989; P. Vezina & Stewart, 1989). These data suggest that D1R 
activation in the VTA is necessary for the sensitizing effect of drugs of abuse.  
Besides mesoaccumben DA system, other structures in the mesocorticolimbic 
system are involved in the induction of sensitization. Medial prefrontal cortex originating 
glutamatergic transmission to the VTA is also necessary for the induction of sensitization 
to repeated psychostimulants (Cador, Bjijou, Cailhol, & Stinus, 1999). It was found that 
infusion of glutamate into the VTA enhances dopamine transmission in the NAc and 
induces motor stimulating effect (P. W. Kalivas, Duffy, & Barrow, 1989).  
Based on the aforementioned evidence, psychostimulants induce DA released 
somatodendritically in the VTA, which can act on D1 receptors located primarily on 
afferents to the VTA, such as GABAergic projections from the NAc and glutamatergic 
pyramidal neurons from the PFC, thus lead to the sensitization to drugs of abuse.  
Primary Neural Substrate of Drugs of Abuse: Mesocorticolimbic Dopamine Circuit 
Role of dopamine in mesocorticolimbic dopamine circuit 
The mesocorticolimbic dopamine circuit is composed of the VTA, where the cell 
bodies of dopaminergic neurons located, and its projection areas, including the NAc, 
amygdala (AMY), hippocampus and the prefrontal cortex (PFC). The mesocorticolimbic 
dopamine circuit is the major substrate of reward and reinforcement for natural rewards. 
 12 
The role of DA in mesocorticolimbic system has been over-simplified, which is usually 
taken as neurotransmitter used in “brain reward system”. The word “reward” is used too 
broadly therefore it might not be the most precise word to describe the main function of 
mesocorticolimbic dopamine system. Most importantly, the term “reward” evokes the 
concept of pleasure or hedonia in readers, which greatly obfuscates the discussion of the 
function of mesocorticolimbic dopamine system. The “brain reward system” also can be 
activated by aversive stimuli, shown from enormous literature (Abercrombie, Keefe, 
DiFrischia, & Zigmond, 1989; Carlson, Herrick, Baird, & Glick, 1987; Cenci, Kalen, 
Mandel, & Bjorklund, 1992). The sensitization effect of many types of stress on 
mesocorticolimbic dopamine circuit will be discussed in detail in the following chapters.    
It is important to note that the consumption of the rewarding material does not 
induce the firing of DA neurons, but the cue predicting the possible rewarding stimuli 
does (Schultz, Dayan, & Montague, 1997). Trained rats exposed to a conditioned 
stimulus signaling that lever pressing would result in sucrose delivery was accompanied 
by an elevation of DA in the NAc, however, the actual presentation and consumption of 
reinforce were not (H. D. Brown, McCutcheon, Cone, Ragozzino, & Roitman, 2011; 
Roitman, Stuber, Phillips, Wightman, & Carelli, 2004).  
Also extensive data suggest that DA transmission does not affect reinforcing 
stimuli-induced hedonia or fundamental motivation, but affects critical features of 
reinforcing stimuli-directed instrumental behavior, such as the sensitivity to the work 
requirements in effort-related tasks, or learning component of operant task (Denk et al., 
2005; Salamone & Correa, 2012). The DA depletion or antagonism in mesolimbic circuit 
does not affect the appetitive taste reactivity to natural reward, but affect the instrumental 
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behavior, such as food seeking behavior, reinforcement learning (Baldo, Sadeghian, 
Basso, & Kelley, 2002; Koob, Riley, Smith, & Robbins, 1978; Salamone, Mahan, & 
Rogers, 1993), suggesting the distinction between instrumental versus consummatory 
behavior (seeking with taking). Therefore, the function of DA in mesocorticolimbic 
system is more specific and complicated than “neurotransmitter mediating reward”, and 
requires further investigation. 
 Bromberg-Martin brought up a theory suggests that separated DA populations in 
mesocorticolimbic circuit encode motivation value, motivational salience, and alerting 
signal triggered by unexpected sensory inputs (Bromberg-Martin, Matsumoto, & 
Hikosaka, 2010). DA neurons are activated and exhibit phasic firing by reward greater 
than expectation or cue predicting the increase in reward value (Bromberg-Martin et al., 
2010). In contrast, most DA neurons are depressed and show phasic pause in response to 
aversive stimuli or cue predicting the decrease of reward value (Brischoux, Chakraborty, 
Brierley, & Ungless, 2009). Phasic burst firing and pause in VTA DA neurons cause 
different pattern of dopamine release in the terminal regions (Grace, 2000). Optogenetic 
stimulation of VTA DA neurons in a phasic burst pattern, but not tonic pattern, induces 
condition place preference, suggested that phasic firing of VTA DA neurons is rewarding 
or reward predictive (H.-C. Tsai et al., 2009). In contrast, negative reward prediction 
errors induce phasic pause in VTA DA neurons, leading to the termination of behavior or 
the avoidance. Interestingly, when the reward is exactly the same as predicted, DA 
neurons show no response (Schultz et al., 1997).  
 Major components and network of mesocorticolimbic dopamine circuit 
Ventral tegmental area 
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  The VTA contains a mixture of DA neurons (~65%), GABAergic neurons 
(~30%), and glutamatergic neurons (~5%) (Fields, Hjelmstad, Margolis, & Nicola, 2007; 
Margolis, Lock, Hjelmstad, & Fields, 2006; Swanson, 1982), some evidence also 
indicates that some VTA DA neurons co-release glutamate (Chuhma et al., 2004; 
Tecuapetla et al., 2010; Yamaguchi, Sheen, & Morales, 2007). The data showed that 
VTA DA neurons in mice can elicit excitatory postsynaptic responses in projection 
neurons of the NAc (Tecuapetla et al., 2010). Also in situ hybridization results show that 
mRNA of vesicular glutamate transporter type 2, a transporter protein necessary for the 
package and secretion of glutamate, is expressed in VTA DA neurons (Yamaguchi et al., 
2007), suggesting that some DA neurons can also release glutamate as neurotransmitter. 
The cyto-architecture of the VTA is not well-defined and is determined largely by 
adjacent structures. VTA DA neurons are heterogeneous in anatomical location and 
connectivity, electrophysiological properties and molecular features (Grace & Bunney, 
1984; Stephan Lammel et al., 2008; S. Lammel, Ion, Roeper, & Malenka, 2011; Schultz, 
2007). Based on the firing pattern, VTA dopamine neurons can be categorized into 
conventional slow-firing dopamine neurons, and unconventional fast-firing dopamine 
neurons with small DAT/TH mRNA expression ratios (Grace & Bunney, 1984; Schultz, 
2007). Based on classical histofluorescence labeling and neural tracing studies, DA 
neurons of the VTA project to limbic and cortical areas along mesolimbic and 
mesocortical pathways (Bjorklund & Dunnett, 2007; German & Manaye, 1993; Marin, 
Herrero, Vyas, & Puelles, 2005). However, with the rapid advance in neural tracing 
techniques and functional studies, this has long been recognized as an oversimplification. 
The DA projections originated from the VTA demonstrate target-specific 
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neurophysiological characteristics. The conventional slow-firing DA neurons project to 
the lateral shell of the NAc and the dorsolateral striatum, and the unconventional fast-
firing DA neurons selectively project to PFC and NAc core and medial shell as well as to 
basolateral AMY (Bjorklund & Dunnett, 2007; Ikemoto, 2007; Stephan Lammel et al., 
2008).  
  With the rapid advance in neurotracing techniques and cell-type specific photo-
stimulation, characterization of the functional connectivity of VTA dopaminergic neurons 
becomes possible. VTA dopaminergic neurons receive both excitatory and inhibitory 
regulation from a complex of brain regions. Lammel and colleagues recently showed that 
lateral VTA-dopamine neurons, which project to the NAc lateral shell, receive 
glutamatergic projection from laterodorsal tegmentum, whereas GABAergic neurons in 
the medial VTA, which inhibit the VTA dopaminergic neurons projecting to the medial 
prefrontal cortex, received excitatory input from lateral habenula glutamatergic neurons 
(S. Lammel et al., 2012).  
It was shown that activation of VTA GABAergic neurons is aversive and 
inhibition of GABAergic neurons is rewarding, and animals will work actively to self-
administer the inhibition of VTA GABAergic neurons (Jennings et al., 2013). Also, the 
bed nucleus of the stria terminalis (BNST) send excitatory glutamatergic and inhibitory 
GABAergic inputs to VTA GABAergic neurons (Kudo et al., 2012). BNST glutamatergic 
neurons were activated whereas BNST GABAergic neurons were suppressed by aversive 
foot shock (Jennings et al., 2013). Also activation of BNST glutamatergic projection to 
the VTA is aversive whereas activation of BNST GABAergic projection in the VTA is 
rewarding (Jennings et al., 2013).  
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Nucleus accumbens 
The NAc integrates reward-related information conveyed by dopaminergic and 
GABAergic inputs from the midbrain with glutamatergic inputs from the forebrain. The 
NAc is composed of two anatomically distinct regions, core and shell (Jongen-Relo, 
Voorn, & Groenewegen, 1994; Zahm, 2000), which received different afferent 
projections and have different projection targets (Heimer, Zahm, Churchill, Kalivas, & 
Wohltmann, 1991). Under this neuroanatomical frame work, the complexity of NAc is 
further layered by multiple neuronal cell types. Approximate 95% of neurons in the NAc 
are medium spiny projection neurons (MSNs), which use GABA (Gamma-aminobutyric 
acid) as the main neurotransmitter, and expressing either D1-like receptors (D1 and D5) 
or D2-like receptors (D2, D3, and D4). D1 receptors are coupled with Gs/Golf, the 
activation of which will stimulate adenylyl cyclase to produce cyclic AMP (cAMP), an 
intracellular secondary messenger. cAMP can activate the cAMP-dependent protein 
kinase (PKA), which will lead to the phosphorylation of downstream enzymes and 
transcription factors involved in synaptic plasticity. D2 receptors are coupled to Gi/Go, 
and tend to inhibit adenylyl cyclase and induce an inwardly rectifying K
+
 current, which 
will lead to the hypopolarization of the neuron. Importantly, activation of D2 auto-
receptors on the dopamine terminals will inhibit release of dopamine (Berhow, Hiroi, & 
Nestler, 1996). Based on radioligand binding studies of dopamine receptors in striatum, 
D1 receptors have lower affinity for dopamine compared with D2 receptors (Creese, 
Sibley, Hamblin, & Leff, 1983), thus will only be activated when synaptic DA level is 
high. In contrast, D2 receptors have high affinity for dopamine, thus are very sensitive to 
the reduction of synaptic DA level. MSNs can express D1R or D2R predominantly, or 
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both D1R and D2R, and these different subtypes of MSNs in the NAc exert balanced but 
antagonistic influences on reward-related behaviors. There is evidence suggesting that 
D2-MSNs in the NAc exert an inhibitory influence on brain rewarding circuitry. 
Activation of MSNs expressing D2 receptors (D2R-MSNs) reduces the reinforcing effect 
of drugs of abuse and suppresses the drug seeking behavior, and the inhibition of D2R-
MSNs leads to enhanced motivation for cocaine (Bock et al., 2013). In contrast to the 
effect of D2-MSNs activation, activation of D1R-MSN has the opposite effect, which 
leads to the increased rewarding effect of cocaine shown by conditioned place preference. 
Such opposite actions of D1 and D2-MSNs is very similar to the cell-type specific role of 
brain-derived neurotrophic factor (BDNF) in this area (Lobo et al., 2010), and role 
BDNF-TrkB signaling in the NAc in sensitization to drugs of abuse will be discussed in 
the following chapters.     
Neurons in the striatum, including the NAc, also have distinct functions in motor 
activity, which are D1 or D2 receptor-specific and neural circuit-specific. The D1 
expressing striatal neurons, which project to the basal ganglia (direct pathway), can 
facilitate body movement; the D2 expressing striatum neurons, which project to the 
globus pallidus (indirect pathway), can inhibit body movements. Due to the difference in 
binding affinity with dopamine, D1R and D2R respond to different pattern of dopamine 
release distinctively. DA neurons phasic burst leads to heightened DA level, which 
primarily activate D1R expressing neurons in direct pathway, and stimulate locomotor 
function to actively pursue the reward. In contrast, negative reward prediction error 
induces pause of VTA DA neuron firing that will produce low DA, and D2R expressing 
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neurons are more susceptible to such change and will be inhibited, thus lead to the 
suppression of movement via indirect pathway.  
These MSNs are supplemented by sparsely distributed cholinergic interneurons 
and GABAergic interneurons. Recently, more evidence suggests that cholinergic 
interneurons in the NAc, which constitute only 3% of the neuronal population, provide 
cholinergic tone for the whole area and play an important role in reward/aversion 
discrimination (M. T. Brown et al., 2012) and modulation of dopamine signaling related 
with the reinforcing effect of cocaine (Mark, Shabani, Dobbs, & Hansen, 2011).   
Prefrontal cortex 
In rodents, the prefrontal cortex (PFC), composed of anterior cingulate (ACG), 
prelimbic (PrL), and infralimbic (IL) cortices, is a major component of the 
mesocorticolimbic circuit. It receives extensive dopaminergic projections from the VTA. 
The PFC is a critical region mediating goal-directed behaviors and impulse control. The 
major projection neurons in the ACG, PrL and IL cortices are pyramidal neurons, which 
send glutamatergic projection to the NAc and the VTA. Cortical inputs to the NAc 
(arising in the prefrontal, anterior cingulate cortices) modulate accumbal function and its 
subsequent inhibitory outputs to the VTA, which can modulate excitability of VTA DA 
neurons and the strength of dopamine transmission in the brain rewarding circuit. The 
loss of control over drug intake is partially due to the disruption of the normal function of 
prefrontal cortex (PFC), which are the regulation of mesolimbic reward pathway and 
higher-order executive function (Goldstein & Volkow, 2011).  
Based on positron emission tomography (PET) and functional MRI (fMRI) brain 
imaging studies in humans, multiple sub-regions of the PFC (ACG, the orbitofrontal, and 
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dorsal lateral prefrontal cortices) showed significant differences in activity between 
addicts and healthy control subjects during tasks involving working memory, decision 
making, inhibitory control, emotion and motivation, and cue reactivity and drug 
administration (Bolla et al., 2004; Ersche et al., 2005; Goldstein et al., 2009). Also 
decreased basal activity in the PFC was found during drug withdrawal (Goldstein & 
Volkow, 2002) and a significant increase after exposure to drug-related cues (Childress et 
al., 1999).   
Mesocorticolimbic circuit in response to psychostimulants and stress 
The function of the mesocorticolimbic dopamine circuit during the induction and 
expression of sensitization had been investigated extensively in the previous several 
decades, and the VTA has been identified as the action site of psychostimulants during 
the induction of sensitization (Paul Vezina & Stewart, 1990). Microinjection of AMPH 
into the VTA, but not the NAc, can induce the behavioral sensitization (P W Kalivas & 
Weber, 1988) and a sensitized dopaminergic response in the NAc  to peripheral 
psychostimulants (Paul Vezina, 1993), suggested that the VTA is necessary for the 
induction of sensitization. In contrast, 6-hydroxydopamine-induced (6-OHDA) 
destruction of DA neurons in the VTA disrupts cocaine self-administration (Roberts & 
Koob, 1982), and prevents AMPH/cocaine induced behavioral sensitization (Kelly, 
Seviour, & Iversen, 1975). Destruction of dopaminergic terminals in the NAc also 
disrupts cocaine and amphetamine self-administration (Roberts, Koob, Klonoff, & 
Fibiger, 1980). The evidence above suggests that VTA DA neurons innervating the NAc 
are necessary for compulsive drug taking behavior. 
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Besides drugs of abuse, stress also can activate the mesocorticolimbic dopamine 
system. Interestingly, mild/acute stress preferentially activates mesocortical dopamine 
transmission and increases extracellular DA levels in the prefrontal cortex (Thierry et al, 
1976). In contrast, higher intensities of stress reduce dopamine levels in the prefrontal 
cortex but increases dopamine transmission in the mesolimbic circuit (Prasad, Sorg, 
Ulibarri, & Kalivas, 1995; Sorg & Kalivas, 1991). This hetero-regulation of 
mesocorticolimbic dopamine transmission by stress suggests that different subpopulation 
of dopamine cells in the VTA are differentially affected by different intensities of stress. 
The stress induced neuroadaptation in the mesocorticolimbic circuit will be discussed in 
more detail in the coming chapters.   
Stress 
Overview on physiological effects of stress 
 Any external threat, real or perceived, which can alter homeostasis, is defined as 
“stress”(Rivier, 1990). Stress takes place in conditions where an environmental demand 
exceeds the natural regulatory capacity of an organism, in particular situations that 
include unpredictability and uncontrollability. The hypothalamus is the principal target of 
stress, which will transduce stress induced neural impulses into hormonal secretion 
(Brodish & Redgate, 1973). Stress induced excitatory inputs first converge on neurons 
located in the paraventricular nuclei of the hypothalamus (PVN), which will release 
corticotrophin-releasing factor (CRF)(M. R. Brown, Koob, & Rivier, 1990). CRF is 
released into hypothalamo-hypophyseal portal vessels, and is carried a short distance to 
the anterior pituitary. In response to CRF, the pituitary gland secrets a hormone, known 
as adrenocorticotrophic hormone (ACTH) into blood. ACTH is carried a long distance to 
 21 
the adrenal cortex. In the adrenal cortex, ACTH promotes the synthesis and secretion of 
corticosteroids. In rat, the major corticosteroid is corticosterone, and in humans it is 
cortisol. Corticosteroid (alternative name: glucocorticoid) can stimulate glucose 
metabolism (gluconeogenesis), facilitate breakdown of fats (lipolysis), and reduce 
glucose uptake (Baxter & Rousseau, 1979). All these effects of corticosteroid lead to 
increased plasma glucose, which provides readily metabolizable fuel for the reaction to 
an emergency.    
 Viewing from a holistic fashion, the response to stressors can be beneficial: it 
helps animals be ready to adapt to the environment and can lead to a positive 
psychological state in some particular situation. HPA-axis stimulation, indexed by the 
level of corticosteroids in response to different types of stimuli in animals is shown in 
Figure 3.  
 However, prolonged exposure to stress or too intensive stressful stimulation could 
cause adaptation failure, wherein the organism reaches a phase of exhaustion and adverse 
consequences will follow. Depression and post-traumatic stress disorders are common 
pathologies induced by chronic stressful experience. Chronic stress also impairs the 
immune system by reducing lymphocytes levels in the circulation. There is a high density 
of steroid-receptors located on lymphocytes, and stress induced elevation of 
corticosteroids leads to excessive activation of those receptors and causes the removal or 
even the destruction of lymphocytes, resulting in the immune-suppressive effects 
(Craddock, 1978).  
Predictability and controllability determine the efficacy of a particular stressor 
(Toates, 1995). The aversive effect of the stressor can be greatly alleviated if the stressor 
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is predictable. For example, when a sound cue preceded the onset of electrical shock, the 
effect of the shock, indicated by stomach ulceration,  is significantly reduced compared 
with un-signaled shock (Guile & McCutcheon, 1984). Also the elevation of 
corticosterone level is greater following unpredictable stress than predictable stress 
(Weiss, 1970). When the stressor is signaled by a cue, the cue acquires a fear-eliciting 
capacity, and the anticipation induces higher corticosteroids than the confrontation of the 
stressor (A. Z. Arthur, 1987). In the absence of the cue, the subjects can relax. However, 
if the stressor is unpredictable, then the whole environment acquires a fear-eliciting 
capacity and the subject can never escapes from the stressful condition (Toates, 1995). 
The aversive effect of stress can be ameliorated if subjects are able to exert control to 
terminate stress or avoid it. For example, rhesus monkeys that had control over the 
stressor, a high-intensity noise, showed normal levels of plasma corticosteroid. In 
contrast, the yoked monkeys, who were exposed to the same amount of stressful 
stimulation, showed significantly elevated levels of corticosteroid (Hanson, Larson, & 
Snowdon, 1976).   
Effect of stress on dopamine transmission in mesocorticolimbic circuit 
 Exposure to various forms of stress can result in a metabolic activation of 
mesocorticolimbic dopamine system. For example, extracellular DA concentration in the 
NAc are increased in response to electric shock, tail pinch, physical restraint, and social 
defeat (Gresch, Sved, Zigmond, & Finlay, 1994; Imperato, Angelucci, Casolini, Zocchi, 
& Puglisi-Allegra, 1992; Tidey & Miczek, 1996). The magnitude and specificity of the 
dopaminergic response to stress depends on the intensity, the duration, and the 
intermittency of stress (A. Y. Deutch, Clark, & Roth, 1990; Thierry, Tassin, Blanc, & 
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Glowinski, 1976). As noted earlier, mild stress selectively influences the metabolic 
activation of the dopaminergic innervation onto the prefrontal cortical areas, whereas 
increases in either the intensity or duration of footshock stress increases DA utilization in 
the NAc as well as in the PFC (Dunn, 1988; Roth, Tam, Ida, Yang, & Deutch, 1988). 
These data suggest that the pattern of stress-induced DA neurons activation is 
differentiated according to different stressful states.  
 The mesocortical DA projection arises primarily from the ventral tegmental area 
(VTA) and terminates mainly on pyramidal neurons in deep layers V and VI of medial 
PFC (mPFC) (Bjorklund et al., 1978; Emson and Koob, 1978; Berger et al., 1991; Carr et 
al., 1999). Many of the PFC neurons project to the VTA and the NAc, and modulate the 
mesolimbic DA system (Sesack and Pickel, 1992; Carr and Sesack, 2000). Interestingly, 
the depletion of mesocortical dopaminergic innervation results in enhanced 
responsiveness of the mesolimbic dopamine circuit to stress (A. Y. Deutch et al., 1990), 
suggesting a homeostasis compensatory mechanism in mesocorticolimbic DA circuit.  
 Stress selectively increases dopamine metabolism in the VTA but not in the 
substantia nigra (Ariel Y. Deutch, Tam, & Roth, 1985), and these data suggest that cell 
bodies of origin of the mesocorticolimbic dopaminergic system are activated by stress in 
contrast to those DA neurons innervating the striatum. Indeed, stress-induced increases of 
dopamine transmission and metabolism were observed in the NAc, but not the dorsal 
striatum (Roth et al., 1988). Therefore the mesolimbic DA neurons appear to be more 
responsive to stress than the striatal DA system. Stress induced increase of DA 
transmission inhibits pyramidal neurons in the PFC (Bunney & Aghajanian, 1976). Also 
the inhibitory effect of DA on PFC neurons appears to be more potent in the deep cortical 
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layers in which the neurons projecting to the striatum are located (Sesack, Deutch, Roth, 
& Bunney, 1989). These data suggest that stress selectively activate dopamine 
transmission and metabolism in mesocorticolimbic circuit.  
Animal models in stress research and the advantage of social defeat stress 
 Many stress models have been employed in animals to study the neuroadaptation, 
physiological and behavioral changes induced by stress. All these experimental stressors 
can be categorized into two types: the exposure to an aversive stimulation or the 
deprivation of a condition which is necessary for homeostasis (L. Lu, Shepard, Hall, & 
Shaham, 2003). To name a few, electrical foot shock, restraint stress, and social defeat 
belong to the first type of stressor, and food/water deprivation, maternal deprivation, 
social isolation belong to the second type of stressor. Also as mentioned above, the 
controllability and predictability determines the efficacy of stress in general. It is 
important to note that the effect of stress on behavior is stressor-specific, schedule-
specific, and intensity-specific. For example, exposure to the same stressor, but in the 
different intermittency and duration, leads to qualitatively different effects on behaviors 
and neurochemistry (Miczek, Nikulina, Shimamoto, & Covington, 2011).  
The stress model used in this dissertation, social defeat stress, is a naturalistic 
intraspecific agonistic encounter. The defeat experience after a brief episode of agonistic 
interaction cannot be habituated upon repeated exposure due to its uncontrollability and 
unpredictability. Because social conflict and aggression behavior is a critical facet of 
natural behavior, it has high face validity in replicating environment change and personal 
defeat experienced in humans, and serves as a biologically relevant mean of examining 
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stress induced vulnerability to drugs of abuse. Social defeat stress is the stress model used 
in the present study. 
During the social defeat stress, a rise of corticosteroid levels in plasma is found in 
both winner and loser rats following conflict. However, the rise was higher and more 
durable in losers than winners. After the corticosteroid levels had returned to baseline, the 
confrontation with a non-aggressive conspecific induced sensitized HPA axis response 
and significantly higher corticosteroids level only in defeated rats (Schuurman, 1981). 
Importantly, the intermittent social defeat stress model and the continuous subordination 
model use the same stressor, intraspecific agonistic encounter, but with different duration 
and intermittency, have totally opposite effect on behaviors. The qualitative difference 
between these two models leads to the activation of distinct brain circuits and behavioral 
outputs. Intermittent social defeat stress will activate VTA-accumbens-PFC-amygdala 
circuit and induce sensitization to stimulant drugs, whereas the continuous subordination 
will activate raphe-PFC-hippocampus circuit and lead to anhedonia-like effects and 
depression (Miczek, Yap, & Covington, 2008). In contrast to intermittent social defeat 
stress, continuous social subordination leads to suppressed locomotor response to cocaine 
challenge, and reduced DA transmission in the NAc and VTA BDNF expression (Miczek 
et al., 2011). In the present studies, we used acute or intermittent social defeat stress 
models, which will sensitize animals to psychostimulants without causing any depressive 
effect.     
It is of great importance to investigate the neural mechanisms underlying the 
social defeat stress induced cross-sensitization to drugs of abuse, which will shed light 
into potential therapy to prevent stress induced vulnerability to addiction.  
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Cross-sensitization Between Psychostimulants and Stress 
 Although the initial drug-taking decision is voluntary for most people, the 
transition from the leisure drug using to compulsive drug taking varies among individuals. 
The predisposition to develop addiction to drugs of abuse depends on the intrinsic 
nervous system and can be heavily affected by stimulation from the environment, such as 
stress. Stress is an etiological factor in the pathogenesis of addiction, which can increase 
the likelihood to develop drug abuse in vulnerable individuals. Stress from the society 
contributes, at least partially, to the soaring number of drug abusers nowadays, 
presumably due to its effect on compulsive drug taking and relapse (Sinha, 2008).  
 Cross sensitization is the augmented response to a specific type of drug of abuse 
induced by some stimuli other than drug. Similar to the sensitization developed during 
repeated drug exposure, exposure to stress also can induce sensitized response to abused 
substances, which engender higher vulnerability to develop addiction. Stress induced 
vulnerability to addiction is a phenomenon found broadly in humans, and has been 
recapitulated by laboratory animal models (Antelman, Eichler, Black, & Kocan, 1980; J. 
J. Yap & K. A. Miczek, 2008). Many forms of stressors were found to be able to augment 
locomotor activity in response to drugs of abuse in animals (Antelman et al., 1980; Piazza, 
Deminiere, le Moal, & Simon, 1990; Tidey & Miczek, 1997).  
Stress sensitizes the mesocorticolimbic dopamine circuit 
  Enhanced DA function in the mesocorticolimbic system, especially in the NAc, is 
the common neural substrate underlying the sensitization to drugs of abuse 
(Vanderschuren & Kalivas, 2000) and stress-induced cross-sensitization. For example, 
forced swim stress can increase the sensitivity of VTA dopamine neurons to excitatory 
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inputs, and this acute stress induced synaptic strength in VTA dopamine neurons can be 
prevented by glucocorticoid receptor antagonist (Saal, Dong, Bonci, & Malenka, 2003). 
Also acute restraint stress leads to increased extracellular dopamine levels in the NAc and 
cross-sensitization to cocaine (Garcia-Keller et al., 2013). Foot shock stress can increase 
dopamine levels in the VTA of cocaine experienced rats but not drug-naïve rats, and such 
an effect can be prevented by intra-VTA infusion of CRF-receptor 2 antagonist (Wise & 
Morales, 2010). Social defeat stress induces similar dopamine response in the NAc and 
motor activity in relative to AMPH challenge (Miczek, Mutschler, van Erp, Blank, & 
McInerney, 1999).  
Extensive evidence suggests that stress induced increase of dopamine 
transmission or the sensitivity of dopamine neurons is mediated, at least partially, by the 
increase of stress hormones. A study by the Wise group (B. Wang et al., 2005) found that 
foot shock induces elevation of glutamate, dopamine and CRF release in the VTA of 
cocaine-experienced rats, accompanied with stress-induced reinstatement to cocaine. 
Such stress induced neurochemical changes and reinstatement can be recapitulated by 
intra-VTA infusion of CRF, or be prevented by either CRF antagonist or inotropic 
glutamate receptor antagonist, kynurenic acid (B. Wang et al., 2005). Taken together, 
foot shock stress induces the release of CRF in the VTA, which can bind with CRF 
receptors on the presynaptic terminals and trigger glutamate release from these terminals 
in the VTA. The elevation of glutamate release in the VTA activates local dopamine 
neurons and leads to the increased release of dopamine, which induces vigorous 
reinstatement. Wang and colleagues further showed that such stress-induced 
neurochemical changes and reinstatement are mediated by CRF2-receptor (B. Wang, You, 
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Rice, & Wise, 2007). Direct infusion of CRF into the VTA increase the sensitivity of 
dopamine neurons to glutamatergic input through the potentiation of N-methyl-D-
aspartate receptor (NMDAR)-mediated synaptic transmission in VTA dopamine neurons 
(Ungless et al., 2003). The potentiation of NMDAR-mediated synaptic transmission leads 
to increased neural activation and Ca
2+
 influx, which can stimulate many downstream 
targets and activity induced gene transcription, such as BDNF. The role of BDNF in 
stress-induced neuroadaptation will be discussed in the following chapters.    
The role of the HPA axis and stress hormones in cross-sensitization 
Both stress and psychostimulants administration enhance dopamine transmission 
from the VTA to the limbic forebrain and cortex (P. W. Kalivas & Stewart, 1991; Tidey 
& Miczek, 1997) and can activate the HPA axis leading to elevated ACTH and 
corticosteroids (Borowsky & Kuhn, 1991; Natelson, Tapp, Adamus, Mittler, & Levin, 
1981).  There are two common substrates in the central nervous system affected by stress 
and drugs of abuse: the mesocorticolimbic dopamine circuit and the hypothalamo-
pituitary-adrenal (HPA) axis. Therefore, “between system cross-sensitization” was not 
restrictive to the changes in the mesocorticolimbic dopamine circuit induced by stress; 
drugs of abuse induce sensitization in both mesocorticolimbic dopamine circuit and brain 
stress system. Many kinds of abused substances such as alcohol, nicotine, 
psychostimulants, and opiates that stimulate mesocorticolimbic dopamine systems also 
activate brain stress systems (Baumann et al., 1995; Cinciripini et al., 1989; Cobb & Van 
Thiel, 1982). Greater behavioral reactivity and bodily responses to stress are found in 
cocaine addicts, reflected the sensitization in both the HPA axis and the autonomic 
nervous system (Abercrombie et al., 1989). Based on evidence from laboratory animals, 
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non-contingent acute cocaine administration increases plasma levels of ACTH and 
corticosteroids, which is mediated by the cocaine induced release of CRF from 
paraventricular nucleus (Goeders, 2002; Sarnyai, Shaham, & Heinrichs, 2001). Also 
clinical research showed that increased secretion of cortisol and ACTH was found in 
cocaine addicts after acute intravenous cocaine administration (Mello & Mendelson, 
1997), and positive correlation between stress and craving for cocaine was found in 
cocaine dependent individuals (Brady et al., 2009). Thus these data suggest a reciprocal 
sensitization process between the brain stress system and the brain reward system which 
can be induced by exposure to stress or drugs of abuse.  
However, elevation of stress hormone and dopamine elevation cannot fully 
explain the persistence of cross-sensitization behavior. There is a study showing that 
behavioral sensitization to drugs of abuse is independent of corticosterone levels (Nelson, 
Kleschen, & Zahniser, 2010). Elevation in dopamine transmission and corticosteroid 
circulation returned to baseline level in a short period of time, but the cross-sensitization 
can last several months. Thus, the enduring nature of cross-sensitization suggests the 
involvement of factors which are capable of inducing long-term neuroplasticity and 
recruiting transcription machinery. Such factors can translate the short-lasting fluctuation 
of neurotransmitters levels into the long-lasting neuroplasticity and gene expression 
changes. BDNF is one such candidate factor. Immediately after social defeat stress, 
psychostimulant challenge-induced stimulation of psychomotor response remained 
insignificant, and only became obvious several days after the defeat. It is important to 
note that BDNF expression in the VTA also remains unchanged immediately after social 
defeat stress, and becomes significantly elevated at least one week after defeat. This 
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similarity between the temporal pattern of cross-sensitization and VTA BDNF expression 
after social defeat stress suggests that the elevation of BDNF in the VTA may underlying 
the persistent cross-sensitization after intermittent social defeat stress (Fanous, Hammer, 
& Nikulina, 2010).  
Role of Mesocorticolimbic BDNF in Stress- and Drug-induced Neuroplasticity 
Overview of the structure of bdnf gene 
Brain-derived neurotrophic factor (BDNF) was the second neurotrophin to be 
discovered and purified; it shows similar amino acid sequence and neurotrophic effect on 
cultured neurons relative to nerve growth factor (Barde, Edgar, & Thoenen, 1982).  
Based on genomic analyses, a total of nine promoters have been identified in 
rodents and human bdnf gene, in the 5’ untranslated region, and one protein coding 3’ 
exon (Aid, Kazantseva, Piirsoo, Palm, & Timmusk, 2007; Pruunsild, Kazantseva, Aid, 
Palm, & Timmusk, 2007). Although alternative splicings produce multiple transcripts of 
BDNF, all of them share the same coding region. Among all 9 promoters found so far, 
promoter IV is sensitively regulated by neural activity, and it contains multiple calcium-
response sequences and calcium-response elements (CRE) to which calcium responsive 
transcription factor (CaRF) and cAMP response-element binding protein (CREB) bind, 
respectively (Metsis, Timmusk, Arenas, & Persson, 1993). The complex BDNF gene 
structure leads to the production of distinctive BDNF transcripts through alternative 
splicing and polyadenylation, which allow brain region-specific, neural type-specific and 
neural activity-specific regulation of BDNF expression. BDNF transcript synthesis can be 
initiated from multiple distinctive promoters, and two types of BDNF transcripts can be 
produced, with either short or long 3’ untranslated regions (3’ UTR), due to the 
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distinctive polyadenylation at two alternative sites. The transcripts with short 3’ UTR are 
restricted in the soma portion, only the transcripts with long 3’ UTR can be localized in 
the distant dendrites (Lau et al., 2010). The long 3’ UTR of the BDNF transcript is 
required for the development of dendritic spines and long-term potentiation (An et al., 
2008).   
Translation, processing and secretion of bdnf gene products 
BDNF expression is tightly regulated by neural activity. Both endogenous 
synaptic activity in response to sensory input (Castren, Zafra, Thoenen, & Lindholm, 
1992) or artificial stimulation which are capable of inducing LTP can lead to the 
expression of BDNF mRNAs (Patterson, Grover, Schwartzkroin, & Bothwell, 1992). 
BDNF is synthesized as pro-BDNF (32 kilodalton, KD) in the cell then proteolytically 
processed into mature BDNF (14 KD). In contrast with the neurotrophic effect of mature 
BDNF via binding with neurotrophin tyrosine kinase receptor type 2 (TrkB), pro-BDNF 
binds with P75
NTR
 and induces neuronal apoptosis (Teng et al., 2005). In addition, pro-
BDNF can be processed in the extracellular space by tissue plasminogen 
activator/plasmin (Pang et al., 2004). In layer II/III of cortical slices, θ-burst stimulation 
induced BDNF synthesis and secretion in its pro-form. Released pro-BDNF can be 
rapidly internalized in perineuronal astrocytes, thereby restricting the availability of 
BDNF at extraneuronal space (Bergami et al., 2008). After internalization in astrocites, 
BDNF undergoes a recycling process, endowing astrocytes with the ability to resecrete 
BDNF upon stimulation. Bedsides internalization of BDNF, astrocytes can sequester 
mature BDNF secretion from neuronal terminals, as a protective mechanism under stress 
(Crish et al., 2013).  It was recently reported that cultured hippocampal neurons primarily 
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store and secrete mature BDNF during neural activity (Matsumoto et al., 2008). However, 
the cellular location and mechanism of the processing of pro-BDNF into mature BDNF 
remain elusive.  
Several transcription factors can regulate transcription of bdnf gene in response to 
neural activity. In general, neurotransmitter binding and membrane depolarization can 
initiate Ca
2+ 
influx through voltage-gated Ca
2+ 
channels, N-methyl-D-aspartate receptors 
(NMDARs), or from the inner stores. As a secondary messenger, Ca
2+ 
can activate 
intracellular signaling pathways which transduce the signal to the nucleus, leading to the 
activation of transcription factors, such as CREB and CaRF. Both CREB and CaRF can 
activate the expression of BDNF (X. Tao, Finkbeiner, Arnold, Shaywitz, & Greenberg, 
1998; Xu Tao, West, Chen, Corfas, & Greenberg, 2002). Another transcription factor 
activated by Ca
2+
, methyl-CpG binding protein 2 (MeCP2), also can regulate BDNF gene 
expression (W. G. Chen et al., 2003). MeCP2 is a transcriptional repressor of the bdnf 
gene and well known for its role in the pathology of Rett syndrome (Chahrour & Zoghbi, 
2007). It selectively binds to the promoter of exon IV of bdnf gene, recruits histone 
deacetylase which can cause DNA methylation in this area, resulting in transcriptional 
repression (P. L. Jones et al., 1998). The promoter region of BDNF exon IV contains 
specific binding sites for both MeCP2 and CREB, and both are phosphorylated in the 
presence of neuronal activity-induced Ca
2+
 elevation. Upon phosphorylation, 
phosphorylated CREB (pCREB) translocates into the nucleus and associates with CRE 
elements in the exon IV promoter of bdnf, thus leading to the transcriptional activation. 
In contrast, phosphorylation of MeCP2 in the MeCP2/HDAC/Sin3A complex will lead to 
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the dissociation of the complex from bdnf gene (W. G. Chen et al., 2003), thus leading to 
the removal of transcriptional repression on the bdnf gene.   
Because bdnf mRNA can be transported to dendrites and translated there in 
response to local stimulation, BDNF can be synthesized both in the soma and the 
dendrites. High potassium depolarization induces elevation of BDNF mRNA levels in 
dendrites of cultured hippocampal neurons. This increase of BDNF mRNA is 
independent of new RNA synthesis occurring in the soma, but is neural activity-
dependent, and requires the presence of extracellular Ca
2+ 
(Tongiorgi, Righi, & Cattaneo, 
1997). Neural activity-induced BDNF expression can be detected in dendrites even when 
transport of BDNF from soma to dendrites is inhibited by nocodazole. However, such 
dendritic BDNF expression can be abolished by the protein synthesis inhibitor, 
cycloheximide (Tongiorgi et al., 1997). These data suggest that bdnf mRNA can be 
transported to dendrites and translated into protein there in response to the local neural 
activation.  
Release of BDNF and intracellular signaling cascade activated by BDNF, and 
reuptake of BDNF  
Due to the essential role of BDNF in synaptic plasticity, the neuroplasticity in the 
mesocorticolimbic circuit can be modulated by the level of BDNF signaling. The release 
of BDNF is mainly Ca
2+
 dependent. Voltage-gated Ca
2+
 channels, NMDA receptors and 
intracellular stores are the major sources of intracellular Ca
2+
, which induces the 
exocytosis of BDNF-containing vesicles (Kolarow, Brigadski, & Lessmann, 2007; 
Kuczewski, Porcher, & Gaiarsa, 2010). BDNF has the high affinity for the TrkB receptor. 
The binding of BDNF with TrkB induces the dimerization of TrkB receptors and the 
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autophosphorylation at tyrosine sites of the receptors (Minichiello, 2009). 
Phosphorylation on the tyrosine sites on the intracellular domain of TrkB provide the 
docking sites for adapter molecules, such as Src homology 2 domain containing adaptor 
protein (Shc). The adaptor proteins link the activated receptor to other enzymes, 
culminating in the activation of at least three signaling cascades: 1) the microtubule-
associated protein kinase (MAPK) pathway, which is involved in neuronal differentiation 
and neurite outgrowth; 2) the phosphatidyl inositol-3 kinase (PI3K)-Akt (serine threonine 
kinase) pathway, which enables cell survival; and, 3) the phospholipase Cγ (PLC 
gamma)-Ca
2+
 pathway, which mediates synaptic plasticity-induced Ca 
2+
 release from 
intracellular stores. An illustration of BDNF-TrkB intracellular signaling pathways can 
be found in Figure 4.  
 It is important to note that BDNF is a critical modulator of activity-induced 
synaptic plasticity (LTP and LTD). BDNF potentiates the efficacy of excitatory synapses 
(E. S. Levine, Dreyfus, Black, & Plummer, 1995) but depresses the efficacy of 
GABAergic synapses (Bolton, Pittman, & Lo, 2000; Tanaka, Saito, & Matsuki, 1997). 
Therefore, elevated BDNF in the VTA may enhance the excitability of DA neurons there.  
BDNF signaling in response to psychostimulants.  
Acute exposure to psychostimulants induces the short-lasting increase of BDNF 
mRNA and protein in the PFC and NAc (Fumagalli, Di Pasquale, Caffino, Racagni, & 
Riva, 2007; Le Foll, Diaz, & Sokoloff, 2005; Saylor & McGinty, 2008), which might be 
mediated by cocaine-induced phosphorylation on MeCP2 and CREB. A progressive 
increase of BDNF expression levels with time was also observed in several regions of the 
mesolimbic circuit (VTA, NAc, and amygdala) up to 90 days after the cessation of 
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cocaine self-administration, accompanied by intensified cue-induced reinstatement and 
increased risk for relapse (Jeffrey W. Grimm et al., 2003), which is defined as 
“incubation of drug craving”.  
Many studies showed that BDNF can enhance behavioral response and sensitivity 
to reinforcing effect of drugs of abuse. The infusion of BDNF protein into the VTA or the 
NAc can induce the sensitization and reinstatement to drug or drug-related cues (Bahi, 
Boyer, Chandrasekar, & Dreyer, 2008; Graham et al., 2007; Guillin et al., 2001; Horger 
et al., 1999; L. Lu, Dempsey, Liu, Bossert, & Shaham, 2004; Vargas-Perez et al., 2009). 
In contrast, reduction of BDNF-TrkB signaling in the NAc can prevent social defeat 
stress induced cross-sensitization to AMPH (our unpublished data) and the psychomotor 
sensitization to meth-AMPH (Narita, Aoki, Takagi, Yajima, & Suzuki, 2003).  
In contrast, BDNF in the PFC showed a different expression pattern in response to 
drugs of abuse compared with BDNF in the NAc. Twenty-two h after the cocaine self-
administration, a reduction of BDNF mRNA levels was observed in the PFC, but such 
reduction is no longer observable 21 days later (McGinty, Whitfield, & Berglind, 2010). 
Also, infusion of BDNF into the PFC after cocaine self-administration attenuates relapse 
and cue/cocaine prime-induced reinstatement of cocaine-seeking after extinction 
(Berglind et al., 2007). These data suggest the brain region-specific effect of BDNF in the 
mesocorticolimbic circuit during sensitization and reinstatement to drugs of abuse.  
BDNF expression in response to social defeat stress. 
As mentioned above, different duration of social defeat stress exposure results in 
the distinct neurochemical and behavioral outputs. The VTA BDNF expression is also 
affected by the duration of social defeat stress exposure. In response to intermittent social 
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defeat stress, VTA BDNF is increased, whereas chronic social defeat stress (continuous 
subordination) leads to the reduction of VTA BDNF. Also long-term behavioral 
sensitization to psychostimulant and facilitated acquisition of drug self-administration are 
found in rats exposed to intermittent social defeat stress (4 defeats in 10 days) (Miczek et 
al., 2011). In contrast, continuous social defeat stress (5 weeks) induces blunted 
sensitization to psychostimulant and acquisition of drug self-administration (Miczek et al., 
2011). Continuous social subordination-induced depression and anhedonia may 
contribute to the blunted response to psychostimulants and reduced reinforcing effect of 
psychostimulants during self-administration. The level of BDNF expression in the VTA 
may determine the behavioral output, either the sensitization to psychostimulants or the 
depression/anhedonia.  
A large preclinical literature shows that stress reduces BDNF expression in the 
hippocampus, whereas chronic antidepressants treatment upregulates BDNF signaling 
(Duman & Monteggia, 2006). A variety of acute (single stress) and chronic (7 to 21 days) 
stress paradigms, including social defeat stress (Pizarro et al., 2004), can decrease the 
expression of BDNF in the hippocampus, which can be reversed by chronic treatment 
with antidepressants (Duman & Monteggia, 2006; Roceri, Hendriks, Racagni, Ellenbroek, 
& Riva, 2002; Ueyama et al., 1997; Xu et al., 2004). More importantly, direct infusion of 
BDNF into the hippocampus induces antidepressant effects (Shirayama, Chen, Nakagawa, 
Russell, & Duman, 2002). In contrast to the antidepressant effect of BDNF in the 
hippocampus, BDNF exerts a potent pro-depressant effect in the mesolimbic circuit 
(Eisch et al., 2003), and increases susceptibility to social defeat stress (Vaishnav 
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Krishnan et al., 2008). Taken together, these data underscore crucial region-specific 
action of BDNF during depression.   
The effect of social defeat stress on BDNF expression is also age dependent. 
Social defeat stress induces robust elevation of BDNF mRNA in hippocampus in 
adolescence, but not in adulthood (Coppens et al., 2011). The coping style during 
agonistic confrontation also affects the level of BDNF expression. A significant increase 
of BDNF mRNA in the NAc was found in reactive coping defeated rats (>65% time 
spent on offensive behavior) than proactive coping defeated rats (<15% time spent on 
offensive behavior) and control handled rats (Coppens et al., 2011).   
BDNF gene polymorphism-induced propensity for drug abuse in humans 
Recently a single-nucleotide polymorphism (SNP) in the human BDNF gene was 
found, which causes a valine-to-methionine change at position 66 (Val66Met) in the 
prodomain of BDNF. Val66Met impairs sorting of BDNF into secretory granules and 
activity-induced BDNF secretion (Z. Y. Chen et al., 2004; Egan et al., 2003). Thus, the 
66Val allele homozygous is associated with higher BDNF secretion in response to 
neuronal stimulation compared with the 66Met allele homozygous and Met/Val 
heterozygous. Higher BDNF 66Val homozygote frequency in people with drug addiction 
was found compared with normal control subjects (Cheng et al., 2005; S. J. Tsai, 2007), 
and more sensitized response to AMPH was reported from BDNF 66Val carriers 
(Flanagin, Cook, & de Wit, 2006). These data suggest that higher activity-induced BDNF 
transmission positively correlates with higher vulnerability and physical response to 
drugs abuse.    
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Transcriptional Mechanism of DeltaFosB in response to Chronic Exposure of Drug 
or Stress        
General background: stability of FosB family transcription factors 
 The acute administration of almost all drugs of abuse induces expression of 
members of the Fos family transcription factors, also called immediately early genes, in 
the NAc. Those Fos family members can couple with Jun family proteins to form the AP-
1 complex of transcription factors, which can bind to AP-1 sites (consensus sequence: 
TGAC/GTCA) in promoter areas of genes and regulate their expression. However, during 
chronic exposure to drugs of abuse, transcription of all other members of Fos family but 
DeltaFosB develop tolerance (Renthal et al., 2008), showing reduced levels of expression 
compared to the level after acute drug exposure. In contrast, the truncated isoform 
DeltaFosB continues to be produced and accumulates to considerable level due to its 
unique stability.  
 DeltaFosB and FosB are encoded by the same fosb gene, and shared the same 
fosb pre-mRNA transcript, which contained 5 exons. The alternative splicing of fosb pre-
mRNA leads to fosb and Deltafosb mRNAs. There is an intron retention (Intron IV) in 
the middle of exon 4 and 5, and during the excision of this 140 nucleotide Intron IV, one 
nucleotide frameshift takes place and a stop codon (TGA) is generated, leading to the 
premature truncation of the protein, which is DeltaFosB. In contrast, processing without 
excision of Intron IV produces the full length fosb mRNA containing all 5 exons (Figure 
5). Therefore, fosb mRNA contains all 5 exons of the mRNA, but Deltafosb mRNA only 
contains exons 1 to 4.  
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 There is no difference between the half-lives of mRNAs of DeltaFosB and FosB 
(Alibhai, Green, Potashkin, & Nestler, 2007). Also both fosB and DeltafosB mRNAs are 
induced in the striatum by acute administration of psychostimulants or stress. In contrast, 
DeltaFosB protein showed unique stability due to two mechanisms. First, DeltaFosB 
lacks the C-terminal 101 amino acids sequence, which contains two degrons domains 
targeted by ubiquitin-mediated degradation (Carle et al., 2007). Second, DeltaFosB can 
be phosphorylated at the N-terminus by casein kinase 2 or other unknown kinases, 
conferring extra stability (Ulery, Rudenko, & Nestler, 2006). Figure 6 shows the amino-
acid sequence of FosB and DeltaFosB proteins.  
Mesolimbic DeltaFosB expression induced by stress or drugs of abuse 
 DeltaFosB is one molecule with a very long half-life induced after chronic 
exposure to drugs of abuse (Hope et al., 1994), which could be responsible for the 
persistence of addictive state after the cessation of the drug exposure. DeltaFosB in the 
NAc is induced by chronic exposure to almost all kinds of drugs of abuse, such as opiates 
(Nye & Nestler, 1996), cocaine (Hope et al., 1994), amphetamine, methamphetamine 
(McDaid, Graham, & Napier, 2006), nicotine (Pich et al., 1997), ethanol, phencyclidine, 
and cannabinoids (Perrotti et al., 2008).  
 A growing body of evidence suggests that DeltaFosB expression in the NAc 
regulates the sensitivity to drugs of abuse. Overexpression of DeltaFosB in dynorphin-
expressing neuron in the NAc and striatum, the neural population in which DeltaFosB 
induction takes place during chronic drugs exposure, can induce sensitization to cocaine 
in drug naïve rats (Kelz et al., 1999). In another study, overexpression of DeltaFosB 
specifically in the NAc was found to be sufficient to increase the sensitivity to the 
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rewarding effect of morphine (Zachariou et al., 2006). In contrast, overexpression of 
DeltaC-Jun, a dominant negative form of C-Jun, which can antagonize the action of all 
Fos family proteins, reduces the rewarding effect of cocaine and prevents some of the 
neurochemical alterations induced by chronic cocaine exposure in the mesocorticolimbic 
circuit (Peakman et al., 2003). Thus DeltaFosB in the NAc is critical for the long-term 
neurochemical changes and increased sensitivity to numerous kinds of drugs of abuse.  
 Besides chronic exposure to drugs of abuse, chronic stress exposure also induces 
DeltaFosB accumulation in terminal regions of the mesocorticolimbic circuit, especially 
in the NAc (Nikulina, Arrillaga-Romany, Miczek, & Hammer, 2008; Perrotti et al., 2004). 
It was also found that DeltaFosB accumulation in the NAc can enhance the resilience to 
social defeat stress (V. Vialou et al., 2010), which suggests that the induction of 
DeltaFosB works as a defensive mechanism in the mesocorticolimbic circuit against the 
aversive effects of chronic stress.  
Chronic exposure to drugs of abuse or unpredictable stress leads to DeltaFosB 
expression in different types of neurons in the NAc: drugs of abuse induce DeltaFosB 
expression in D1-NAc neurons, while stress induces DeltaFosB in both D1- and D2-like 
receptor-expressing NAc neurons (Perrotti et al., 2004).    
Potential interaction between DeltaFosB and BDNF signaling pathway  
 DeltaFosB mediates function through the regulation of many downstream genes 
leading to the long-term neuroplasticity in the brain (McClung et al., 2004). VTA BDNF 
overexpression per se induces DeltaFosB accumulation in the PFC and NAc, the major 
terminal regions of the mesocorticolimbic circuit. Also increased colocalization of BDNF 
and DeltaFosB in the NAc, prelimbic (PrL) cortex and medial amygdala was found in 
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rats exposed to intermittent social defeat stress (Nikulina, Lacagnina, Fanous, Wang, & 
Hammer, 2012). A representative image of BDNF/ DeltaFosB double labeling in the NAc 
can be found in the Figure 7.  
 It is important to note that MSNs, the major neuronal population in the NAc 
produce very low levels of BDNF. Therefore the strong immunoreactivity of BDNF 
found here (Figure 7) suggests that considerable level of BDNF is received and 
retrogradely transported to the soma of MSNs in the NAc. BDNF is known to be 
retrogradely transported from nerve terminals to cell body regions after binding to the 
TrkB receptor (DiStefano et al., 1992). Therefore, BDNF innmunoreactivity in MSNs 
could represent the level of BDNF signaling received, internalized, and retrogradely 
transported to the some in these neurons. The increased colocalization of BDNF and 
DeltaFosB after intermittent social defeat stress implicates a potential interaction between 
BDNF signaling and DeltaFosB expression in these neurons. In addition, overexpression 
of BDNF in the VTA induces significant increase of DeltaFosB in the NAc shell (J. 
Wang et al., 2013), suggesting that enhanced BDNF projections from the VTA to the 
NAc may be responsible for accumulation of DeltaFosB in the NAc shell. However, there 
are no biochemical data about the direct interaction between BDNF signaling cascades 
and DeltaFosB expression. Based on the literature, VTA BDNF may prime the 
transcriptional potential of fosb gene by stimulation of the TrkB receptor - extracellular 
signal-regulated kinase (ERK) - cAMP response element binding protein (CREB) 
signaling pathway (J. S. Arthur et al., 2004; Lonze & Ginty, 2002). Activated CREB 
recruits CREB binding protein (CBP) to elevate histone H4 acetylation in the promoter 
region of the fosb gene (A. A. Levine et al., 2005), which increases the accessibility of 
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fosb promoter and up-regulates transcription. Whether there are epigenetic changes on 
the histone modifications around the promoter region of the fosb gene induced by BDNF 
signaling is the topic of future study. The investigation of this potential interaction and 
the underlying molecular mechanism will shed light into the persistence of intermittent 




Chapter 2  
BDNF OVEREXPRESSION IN THE VTA PROLONGS SOCIAL DEFEAT 
STRESS-INDUCED CROSS-SENSITIZATION TO AMPHETAMINE AND 
INCREASES DELTAFOSB EXPRESSION IN MESOCORTICOLIMBIC 
REGIONS OF RATS 
Abstract  
Social defeat stress induces persistent cross-sensitization to psychostimulants, but 
the molecular mechanisms underlying the development of cross-sensitization remain 
unclear. One candidate is brain-derived neurotrophic factor (BDNF). The present 
research examined whether ventral tegmental area (VTA) BDNF overexpression would 
prolong the time-course of cross-sensitization after a single social defeat stress, which 
normally produces transient cross-sensitization lasting less than one week. DeltaFosB, a 
classic molecular marker of addiction, was also measured in mesocorticolimbic terminal 
regions. Separate groups of intact male Sprague-Dawley rats underwent a single episode 
of social defeat stress or control handling, followed by amphetamine challenge 3 or 14 
days later. AMPH cross-sensitization was apparent 3 but not 14 days after stress. Intra-
VTA infusion of adeno-associated viral (AAV-BDNF) vector resulted in a two-fold 
increase of BDNF level in comparison with the group receiving the control virus (AAV-
GFP), which lasted at least 45 days. Additionally, overexpression of BDNF in the VTA 
alone increased DeltaFosB in the nucleus accumbens (NAc) and prefrontal cortex.  
Fourteen days after viral infusions, a separate group of rats underwent a single social 
defeat stress or control handling and were challenged with amphetamine (AMPH) 14 and 
24 days after stress.  AAV-BDNF rats exposed to stress showed prolonged cross-
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sensitization and facilitated sensitization to the second drug challenge. 
Immunohistochemistry showed that the combination of virally enhanced VTA BDNF, 
stress, and AMPH resulted in increased DeltaFosB in the NAc shell compared to other 
groups. Thus, elevation of VTA BDNF prolongs cross-sensitization, facilitates 
sensitization, and increases DeltaFosB in mesocorticolimbic terminal regions. As such, 
elevated VTA BDNF may be a risk factor for drug sensitivity.   
Introduction 
Cross-sensitization is defined as the augmented behavioral response to a drug 
challenge produced by intermittent exposure to an agent other than the challenge drug, 
such as stress or another drug (Antelman et al., 1980; Stewart & Badiani, 1993). In 
humans, stressful life events increase vulnerability to drugs of abuse, particularly 
psychomotor stimulants (Sinha, 2008). Likewise, it has been demonstrated in animal 
models that various forms of stress can increase sensitivity and vulnerability to drugs of 
abuse (de Jong, Wasilewski, van der Vegt, Buwalda, & Koolhaas, 2005; Miczek, 
Covington, Nikulina, & Hammer, 2004; Nikulina, Covington, Ganschow, Hammer, & 
Miczek, 2004; Piazza et al., 1990; Terry E. Robinson, Angus, & Becker, 1985).  
The mesocorticolimbic circuitry is comprised of the ventral tegmental area (VTA), 
where dopamine neurons are located, and its projection areas: the prefrontal cortex (PFC), 
nucleus accumbens (NAc), hippocampus and amygdala (Swanson, 1982). Both stress and 
psychostimulants activate the mesocorticolimbic dopamine system and increase 
dopamine release in VTA terminal regions (Di Chiara & Imperato, 1988; Tidey & 
Miczek, 1996). Although aversive social events such as social stress can increase 
vulnerability to the development of drug sensitization, not all individuals exposed to 
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social stress become sensitized to drugs of abuse. These differences may result from 
individual genetic differences.   
One candidate gene for such individual differences is brain-derived neurotrophic 
factor (BDNF). Genetic addiction studies in humans have determined that a 
polymorphism in the bdnf gene is associated with vulnerability for polysubstance abuse 
(George R. Uhl, Liu, Walther, Hess, & Naiman, 2001). In particular, the presence of the 
BDNF 66Val allele, which confers greater activity-dependent secretion of BDNF 
compared to the BDNF 66Met allele (Egan et al., 2003), is associated with greater 
vulnerability to drug addiction (Cheng et al., 2005; Flanagin et al., 2006; S. J. Tsai, 2007). 
This finding, coupled with the fact that BDNF plays an important role in survival of 
dopamine neurons (Baquet, Bickford, & Jones, 2005), activity-dependent neural 
plasticity (Cohen-Cory, Kidane, Shirkey, & Marshak, 2010), and learning and memory 
(Bekinschtein et al., 2008), places BDNF in a good position to influence response to both 
stress or drugs of abuse.  
Several lines of research support a role for VTA BDNF in stress- and drug-related 
behavior. In rodents, intermittent social defeat stress elevates BDNF expression in the 
VTA (Fanous et al., 2010) and produces lasting cross-sensitization to amphetamine 
(AMPH) (Nikulina et al, 2004). Furthermore, infusion of BDNF into the VTA increases 
locomotor response to cocaine (Pierce & Bari, 2001), and facilitates drug sensitization 
(Horger et al., 1999). In contrast, depletion of BDNF in the VTA prevents the social 
aversion induced by chronic social defeat stress and increases general social interaction 
(Berton et al., 2006; Fanous, Terwilliger, Hammer, & Nikulina, 2011). As VTA BDNF is 
involved in modulating responses to both social defeat stress and psychostimulants, VTA 
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BDNF may play a role in sensitivity to psychostimulants after social defeat stress. The 
present study examined the association between enhanced VTA BDNF and increased 
vulnerability to cross-sensitization and sensitization to AMPH in the presence of social 
defeat stress. 
Another factor that may affect stress-induced sensitization to psychostimulants is 
DeltaFosB, a truncated form of the FosB transcription factor. DeltaFosB is considered a 
molecular marker for chronic stimulation of reward circuitry, stress-induced 
neuroplasticity and sensitization to psychostimulants. DeltaFosB, barely detectable 
immediately after acute stimuli, accumulates to considerable levels
 
after repeated social 
defeat stress or repeated drug administration, and persists due to its stability (Nestler, 
Kelz, & Chen, 1999; Nikulina et al., 2008; Perrotti et al., 2004). DeltaFosB regulates the 
expression of many neuroplasticity-related genes in reward circuitry after chronic drug 
exposure (McClung et al., 2004), and increased DeltaFosB in reward circuitry enhances 
the sensitivity to psychostimulants such as cocaine (Kelz et al., 1999). In the current 
study, we characterized DeltaFosB in VTA terminal regions as a molecular marker for 
long term sensitization related to neuroadaptive changes.   
Here we over-expressed BDNF in the VTA using an adeno-associated virus 
(AAV) vector  to examine effects on AMPH sensitization in two non-sensitizing 
behavioral manipulations: 1) long-term cross-sensitization after a single episode of social 
defeat stress and 2) sensitization after non-sensitizing repeated dosing regimen of AMPH 
injections (Segal & Mandell, 1974). We chose a single social defeat paradigm because 
single social defeat stress-induced effects are transient (de Jong, Wasilewski, et al., 2005; 
Miczek, Nikulina, Kream, Carter, & Espejo, 1999) in comparison with intermittent social 
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defeat stress that result in long-lasting cross-sensitization (H. E. Covington, 3rd & 
Miczek, 2001; Fanous et al., 2010; Nikulina et al., 2004). We also investigated whether a 
single social defeat stress exposure in the presence of elevated VTA BDNF could induce 
long-lasting DeltaFosB expression in mesocorticolimbic projection regions.  
Material and Methods 
Animals 
 Subjects were male Sprague-Dawley rats (Charles River Laboratories, Hollister, 
CA). Rats weighed 225–250 g upon arrival and were acclimated to laboratory conditions 
for one week prior to the start of experiments. All subjects were maintained under a 
reverse light/dark cycle (12 h: 12 h, lights off at 0900 h) with unlimited access to food 
(Purina Rodent Diet, Brentwood, MO) and water. After the acclimation period, rats 
underwent stereotaxic surgery, and were single housed for the remainder of study in 
standard plastic cages (25×50×20 cm). Male Long-Evans rats (Charles River 
Laboratories), termed “residents,” were pair-housed with females in larger (37×50×20 cm) 
cages. Residents were screened for aggressive behavior as described previously (Nikulina 
et al., 2004). All experimental procedures were approved by the Arizona State University 
Institutional Animal Care and Use Committee and conducted in accordance with the 
Guide for the Care and Use of Laboratory Animals (National Research Council, 1996). 
All efforts were used to minimize suffering and to limit the number of animals used.  
Viral vector 
Pseudotyped AAV2/10 vectors were used in all experiments. The AAV2/10 
rep/cap plasmid provided the AAV2 replicase and AAV10 capsid genes (Gao et al., 
2002), while adenoviral helper functions were supplied by the pHelper plasmid 
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(Stratagene, La Jolla, CA). The AAV plasmids contain a transgene cassette, which 
consists of the cytomegalovirus (CMV) promoter, and either the gene for rat BDNF fused 
to enhanced green fluorescent protein or GFP alone (GFP gift from R. Klein), followed 
by a combined intron/polyadenylation signal derived from SV40. These elements are 
flanked by two AAV2 inverted terminal repeats. A standard triple transfection protocol 
was used to generate the helper-free pseudotyped AAV2/10 vectors as previously 
described (Xiao, Li, & Samulski, 1998). Briefly, the three plasmids were co-transfected 
into HEK-293 cells (Stratagene, La Jolla, CA) via calcium phosphate precipitation. Cells 
were harvested 48 h later, resuspended in DMEM, freeze-thawed with dry ice-ethanol 
slurry three times and centrifuged to produce a clarified cell lysate. The resulting viral 
stocks produced either GFP (AAV-GFP, as control virus) or BDNF-GFP (AAV-BDNF) 
upon infection, and were stored at -80°C prior to use.  
Intracranial viral infusion   
Rats were anesthetized with isofluorane and positioned in a stereotaxic frame 
(Leica Angle Two; Richmond, IL). Two holes were drilled at stereotaxic coordinates (AP 
−5.1 mm; ML ±2.15 mm from the bregma) on the surface of skull, and Hamilton syringes 
(Model 7105 KH; Reno, NV) with 24 gauge injector tips were lowered through the holes 
bilaterally at a 10° angle until needle tips reached the VTA (AP −5.1 mm; ML ±0.6 mm; 
DV −8.8 mm from the bregma; Paxinos and Watson, 2007); 0.5 µl of virus was 
bilaterally infused into each side of the VTA for 10 min at a speed of 0.05 µl/min. After 
infusion, the syringes remained in the infusion sites for 5 min to prevent retrace of virus.  
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Confirmation of viral efficacy  
To confirm viral efficacy in enhancing VTA BDNF at the relevant time-points for 
the behavioral experiments, we examined VTA BDNF expression by BDNF 
immunohistochemistry 14 and 45 days after viral infusions. Rats received AAV-GFP or 
AAV-BDNF. One cohort of rats was used only to measure VTA BDNF expression 14 
days after viral infusions. Measurement of VTA BDNF expression 45 days after viral 
infusions was performed in tissue from the rats used in Experiment 2 below.  
All placements of infusion sites were confirmed based on observation of GFP 
expression in serially-collected brain sections. The cases in which infusion sites were 
inaccurate were excluded from further assessment. 
Experimental design 
A timeline of the experiments is presented in Figure 8. Based on the finding that 
VTA BDNF is elevated from two weeks to at least 45 days after viral infusions 
(described in Results below), we waited at least two weeks after the viral infusion to 
commence any experimental procedures.    
Experiment 1: Time-course of a single social defeat stress-induced cross-
sensitization  
Rats were randomly assigned to 4 groups, exposed to either a single social defeat 
stress or handling procedure, then received d-amphetamine sulfate (1.0 mg/kg, i.p.; 
Sigma-Aldrich; St. Louis, MO) either 3 days (n = 6 each) or 14 days (n = 4 and 5, 
respectively) after defeat or the handling procedure (Figure 8A). Following AMPH 
challenge, locomotor activity was tracked and assessed. 
Experiment 2: Molecular alterations induced by VTA BDNF overexpression   
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Rats received bilateral intra-VTA infusion of either AAV-GFP (n= 4) or AAV-
BDNF (n = 7). Two weeks after the surgery, rats were handled, followed two weeks later 
by 0.9% saline (1.0 ml/kg, i.p.) injection. Brain tissue was collected and processed 45 
days after viral infusion surgery (Figure 8B). BDNF in the VTA and DeltaFosB 
expression in the PFC and NAc were examined.   
Experiment 3: Effect of single social defeat stress and VTA BDNF overexpression 
on behavioral sensitization to AMPH and molecular alterations  
Rats were randomly assigned to four groups based on 2 experimental factors: 
virus (AAV-GFP vs. AAV-BDNF) and behavioral treatment (handling vs. single social 
defeat). The groups were: AAV-GFP-handled (n = 7), AAV-GFP-stressed (n = 7), AAV-
BDNF-handled (n = 8), and AAV-BDNF-stressed (n = 7). The stressed groups underwent 
a single social defeat stress exposure two weeks after the surgery, at which time the 
handled groups were handled, followed by two AMPH (1.0 mg/kg, i.p.) challenge 
injections 14 and 24 days after stress. To examine whether prolonged cross-sensitization 
was induced by VTA BDNF overexpression in rats exposed to single social defeat stress, 
the first AMPH challenge was given two weeks after defeat or handling. Three rats were 
excluded from this study due an artifact during locomotor tracking. The second AMPH 
challenge was given 10 days later (24 days after defeat stress; one rat was excluded due 
to an artifact during tracking). All animals were euthanized at day 45 after surgery, 
whereupon brain tissue was collected and processed (Figure 8C). Besides locomotor 
activity, BDNF single labeling and BDNF/TH double labeling in the VTA, and 
DeltaFosB expression in the PFC and NAc were examined. The sample numbers of 
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different immunohistochemical procedures varied due to the exclusion of samples with 
occasional heterogeneity of section quality.    
Social defeat stress  
Social defeat stress consisted of a short aggressive confrontation between an 
aggressive resident rat and an experimental intruder rat as described in detail previously 
(Nikulina et al., 2004). After removing the female from the resident’s cage, an 
experimental intruder rat was placed into the home cage of a resident male rat under a 
stainless steel protective cage (15×25×15 cm) for 5 min, then the protective cage was 
removed, and the resident displayed aggressive behavior; “defeat” occurred when the 
intruder exhibited a supine posture for at least 4 s. Aggressive interactions were 2–5 min 
in duration. The protective cage was then replaced for an additional 15 min exposure, 
after which the intruder was returned to its home cage. Control rats were handled and 
weighed on the days their counterparts were stressed and weighed. 
Locomotor tracking 
For two consecutive days immediately before AMPH challenge, rats were given a 
0.9% saline injection (1.0 ml/kg, i.p.) in their home cages.  Rats inside their home cages 
were placed into the locomotion tracking arena for 1 h to acclimate to the testing 
environment and injection procedure. On the drug challenge day, rats were placed into 
the locomotion tracking arena within their home cages, habituated to the testing 
environment for 30 min during which locomotion was tracked, injected with saline 
followed by tracking for 40 min, then challenged with AMPH followed by tracking for 
70 min. Peak locomotor activity in response to AMPH was achieved 10 – 50 min after 
challenge. Locomotor activity was assessed using Videotrack (Viewpoint Life Sciences; 
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Montreal, Canada); total distance travelled in the form of large ambulatory movements 
(greater than 10 cm) was measured in 10 min bins. The dosage of AMPH used herein 
mainly induces large ambulatory movements (Geyer, Russo, Segal, & Kuczenski, 1987), 
so total distance of such movements can be used as an indicator of the extent of 
psychomotor sensitization in response to AMPH. 
Perfusion and tissue processing 
Forty-five days after surgery, all rats were deeply anesthetized with sodium 
pentobarbital (100 mg/kg, i.p.) and perfused transcardially with 10 ml of 10% heparin in 
0.1 M phosphate-buffered saline (pH 7.4) followed by 250 ml of 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.4). Brains were post-fixed for 1.5 h in the same fixative at 
4°C, soaked in 12.5% sucrose, then in 25% sucrose in 0.1 M PBS at 4°C until saturated, 
then stored at 4°C prior to sectioning.  Brains were sectioned at 20 µm in a cryostat at 
−22°C, and thaw-mounted onto glass slides (Superfrost Plus; Fisher; Waltham, MA). 
Sections were collected from +3.2 to +2.8 mm from bregma for the PFC, +1.8 to +0.8 
mm from bregma for the NAc, and −4.8 to −5.6 mm from bregma for the VTA (Paxinos, 
2007).   
Immunohistochemistry 
Sections were washed in 0.05 M potassium phosphate-buffered saline (KPBS), 
then blocked for 1 h in 10% normal donkey serum and 0.4% Triton X-100 in 0.05 M 
KPBS. Sections were then incubated with primary antibody: BDNF (AB1779SP, 1:3,000 
dilution; Millipore; Temecula, CA) or FosB (SC-48, 1:10,000 dilution; Santa Cruz 
Biotechnology, Inc.; Santa Cruz, CA). The FosB antibody used here targets the N 
terminal of FosB protein contained in both FosB and DeltaFosB. However, based on the 
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timeline of the present research, FosB-like labeling would primarily capture 
accumulation of DeltaFosB because FosB expression is transient and only DeltaFosB 
persists after stimulation (Perrotti et al., 2004). Following incubation with primary 
antibody for 48 h at 4°C, slides were washed in 0.05 M KPBS and incubated for 1 h in 
biotin-conjugated goat anti-rabbit serum (1:200 dilution in blocking solution, Vectastain 
ABC kit; Vector Laboratories; Burlingame, CA). After washing in 0.05 M KPBS, 
sections were incubated with avidin–biotin–peroxidase complex (ABC kit, Vector 
Laboratories) for 1 h, then washed again and developed using DAB chromogen with 
nickel (DAB Peroxidase Substrate kit, Vector Laboratories). After dehydration in graded 
concentrations of ethanol and xylene, coverslips were applied. 
To examine the cellular localization of BDNF expression in the VTA of animals 
that showed persistent cross-sensitization, we performed fluorescent double labeling of 
BDNF and tyrosine hydroxylase (TH). Primary antibodies, rabbit anti-BDNF (AB1779SP, 
1:500 dilution; Millipore; Temecula, CA) and mouse anti-TH (SC-7837, 1:500 dilution, 
Santa Cruz Biotechnology; Santa Cruz, CA), were applied simultaneously and incubated 
for 48 h at 4°C. After incubation with biotinylated goat anti-rabbit IgG (1:200 dilution, 
Vector Laboratories) for 1 h, Alexa Fluor 488 Anti-Rabbit conjugated streptavidin and 
Alexa Fluor 548 Goat Anti-Mouse (1:500 dilution, Invitrogen, San Diego, CA) were 
applied for 2 h. After washing with 0.05 M KPBS, coverslips were applied with ProLong 
Gold Antifade Reagent with DAPI (Invitrogen, San Diego, CA).  
Image analysis 
Tissue sections were examined for the presence of chromogen or fluorophore 
reaction products using a Zeiss Axioskop microscope with 20× or 40× objectives; 
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selected areas were captured and digitized using a color digital video camera (MBF 
Biosciences; Williston, VT) or AxioCam MR (Zeiss) interfaced to the microscope. A cell 
profile was considered labeled if its pixel intensity was more than 2 standard deviations 
greater than the background, as calculated by Stereo Investigator software (MBF 
Biosciences). Fluorescent-labeled cells were counted manually, first in single channels 
for single labeling, then in merged channels for double labeling. At least three adjacent 
sections were analyzed for each brain region per animal, and labeling density was 
calculated by dividing the estimated total number of labeled profiles by the total area 
analyzed.   
Statistics 
In experiment 1, one-way ANOVA (between subjects factor: handling vs. stress) 
was used to analyze locomotor activity during the peak locomotor response period (10 – 
50 min after AMPH injection). In experiment 2, one-way ANOVA was used to analyze 
the number of BDNF or DeltaFosB-labeled cells in saline-treated animals (between 
subjects factor: AAV-BDNF vs. AAV-GFP). In experiment 3, locomotor activity and 
immunohistochemical data were analyzed by two-way ANOVA (between subjects 
factors: viral vector [AAV-BDNF vs. AAV-GFP] and behavioral treatment [handling vs. 
stress]).  Three-way mixed ANOVA with repeated measures (two between subjects 
factors: viral vector [AAV-BDNF vs. AAV-GFP] and behavioral treatment [handling vs. 
stress]; one within subjects factor: number of AMPH injections [first vs. second]) was 
used to analyze locomotor activity in response to the first and the second AMPH 
challenge. In a few cases, an optical artifact produced an unrecoverable error in 
locomotor tracking. Therefore, several cases were excluded due to the presence of this 
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artifact. To assure that the same cases were assessed repeatedly across both challenge 
sessions by three-way ANOVA with repeated measures, samples with such artifact in 
either of the two AMPH challenges were excluded. Thus, the final number of cases 
assessed using three-way mixed ANOVA with repeated measures is n = 6 per group. 
T-test was used for planned comparisons between AAV-BDNF-stressed and all 
other groups when significant interaction was not present, and post-hoc Tukey test was 
used in the presence of significant interaction. All data are reported as mean ± SEM. 
Results were considered significant if p ≤ 0.05.   
Results 
Experiment 1  
Time-course of single social stress-induced cross-sensitization  
To measure the time-course of single social defeat stress-induced cross- 
sensitization in naive rats, locomotor response to AMPH challenge was evaluated in adult 
male Sprague-Dawley rats 3 or 14 days after exposure to a single social defeat or control 
handling. Rats exposed to single social defeat 3 days earlier exhibited significantly more 
total locomotor activity after AMPH than rats handled 3 days earlier (measured 10 - 50 
min after AMPH challenge; F(1, 11) = 7.170, p = 0.023; Figure 9A), reflecting the presence 
of cross-sensitization. No difference in total locomotor activity was observed between 
stressed and handled rats in a separate cohort that were challenged with AMPH 14 days 
after exposure to single social defeat stress or handling (F(1, 7) = 0.230, p = 0.646; Figure 
9B). This indicates that cross-sensitization after a single defeat is short-lasting and 
detectable 3 days, but not 14 days later.  
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Experiment 2  
Confirmation of viral efficacy 
The viral infusion site was visualized using GFP as an indicator of transfection 
(Figure 10A). Based on GFP expression from serially collected sections, we observed 
that transfected neurons in the VTA extend approximately 300µm in diameter on the 
rostral-caudal axis, and 200 μm in diameter on dorsal-ventral and medial-lateral axes 
around the infusion site. Expression of viral product at forty-five days after infusion is 
consistent with the observation that AAV-mediated transgene expression persists 1-3 
months in neurons after transfection (Klein et al, 1998). To compare increase in VTA 
BDNF after AAV-BDNF across time-points, VTA BDNF expression was normalized to 
that of the AAV-GFP control group at each respective time-point (Figure 10C). Fourteen 
and 45 days after viral infusion, we observed two fold increase of BDNF in rats receiving 
AAV-BDNF compared to those receiving AAV-GFP: 14 days F(1,7) = 11.105, p = 0.013; 
Figure 9C;  45 days F(1, 9) = 7.312, p = 0.027; Figure 10B, C, D). At both 14 and 45 days, 
the volume of infection was approximately 25% of the rostral VTA (bregma -4.8 to -5.6) 
around the infusion site (bregma -5.1). 
DeltaFosB expression after BDNF overexpression in the VTA of drug-naïve rats 
VTA BDNF overexpression alone increased DeltaFosB labeling in anterior 
cingulate (ACG; F(1, 6)  = 9.880, p = 0.020), prelimbic (PrL; F(1, 6) = 12.930, p = 0.007) 
and infralimbic (IL; F(1, 6) = 15.620, p = 0.008) regions of the PFC (Figure 11A, C), and 
in the NAc core (F(1,8) = 16.108, p = 0.043) and shell (F(1,8) = 11.978, p = 0.011; Figure 
11B, C) compared to the AAV-GFP-saline rats.  
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Experiment 3  
Social defeat stress-induced cross-sensitization and sensitization to AMPH 
To determine whether elevated VTA BDNF prolonged single social defeat stress- 
induced cross-sensitization, rats receiving AAV-GFP control virus or AAV-BDNF were 
exposed to a single episode of stress or handling followed by AMPH (1.0 mg/kg) 14 days 
later. The absence of stress-induced cross-sensitization to AMPH 14 days later 
(Experiment 1) was confirmed in rats which received AAV-GFP (one-way ANOVA, F(1, 
12) = 1.873, p = 0.198). By contrast, AAV-BDNF-stressed rats showed significantly 
greater locomotor activity in response to the first AMPH injection compared to AAV-
BDNF-handled rats (one-way ANOVA, F(1, 12) = 4.730, p = 0.050). Two-way ANOVA 
showed significant main effects of stress (F(1, 23) = 6.228, p = 0.020) and AAV-BDNF (F(1, 
23) = 4.464, p = 0.046), but the interaction between the two factors was not significant (F(1, 
23) = 0.277, p = 0.603; Figure 12A). Ten days after the first AMPH challenge, a second 
AMPH challenge was given, and a significant main effect of AAV-BDNF (F(1,25) = 8.284, 
p = 0.008) and interaction between stress and AAV-BDNF on locomotor activity was 
observed (F(1,25) = 5.950, p = 0.022), but we observed no main effect of stress (F(1,25) = 
1.587, p = 0.219; Figure 12B). Additionally, AAV-BDNF-stressed rats showed 
significantly greater locomotor activity than AAV-GFP-handled, AAV-GFP-stressed and 
AAV-BDNF-handled groups in response to the second AMPH injection (post-hoc 
multiple comparisons: p = 0.008, p = 0.001 and p = 0.014, respectively; Figure 12C). 
To examine locomotor response to a non-sensitizing AMPH dose regimen in rats 
with a history of stress exposure and enhanced VTA BDNF, we compared locomotor 
activity in response to first and second AMPH challenges within each group (Figure 12C). 
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Analysis of the amplitude of variation of locomotor activity between the first and the 
second AMPH challenge was achieved using three-way ANOVA with repeated measures. 
The data showed significant interaction of AAV-BDNF and number of AMPH injections 
(F(1,22) = 4.503, p = 0.045). Also, a significant interaction among stress, AAV-BDNF, and 
number of AMPH injections (F(1,22) = 5.463, p = 0.029) was observed. Furthermore, 
AAV-BDNF-stressed rats showed significantly augmented locomotor response to the 
second AMPH injection compared to the first AMPH injection (post-hoc multiple 
comparisons: p = 0.031) indicating facilitated sensitization after repeated dosing. 
Although a weak increasing trend was present in AAV-GFP-handled rats in response to 
multiple AMPH injections, this effect was not statistically significant (p = 0.09). No 
significant changes in locomotion after AMPH was observed in AAV-GFP-stressed or 
AAV-BDNF-handled rats (post-hoc multiple comparisons: p = 0.418, p = 0.241, 
respectively, Figure 12C).  
BDNF expression in VTA dopaminergic neurons  
To characterize the distribution and phenotype of BDNF-expressing neurons in 
the VTA, double-label fluorescent immunohistochemistry was performed on tissue from 
Experiment 3. Two-way ANOVA of the total number of BDNF expressing neurons in the 
rostral VTA also indicated a significant main effect of AAV-BDNF (F(1, 22) = 41.381, p = 
0.001) and an interaction between AAV-BDNF and stress approaching significance (F(1, 
22) = 4.055, p = 0.056). Also, AAV-BDNF-stressed rats showed higher BDNF labeling 
across the entire rostral VTA compared to all other groups (Figure 13A; post-hoc 
comparisons: p ≤ 0.05 for all comparisons) 
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Furthermore, two-way ANOVA showed significant main effect of AAV-BDNF 
on BDNF/TH double-labeled cells in the rostral VTA (F(1, 22) = 14.298, p = 0.001); and 
significantly more BDNF/TH double-labeled cells were present in the rostral VTA in 
AAV-BDNF-stressed rats than in AAV-GFP-handled or stressed rats (t-test: p = 0.018 
and p = 0.001, respectively; Figure 13B, C).  
DeltaFosB in the mesocorticolimbic projection areas  
Consistent with the effect of VTA BDNF overexpression on DeltaFosB 
expression in PrL and ACG cortices in drug naïve rats (experiment 2), two-way ANOVA 
showed a significant main effect of AAV-BDNF on DeltaFosB expression in both the 
ACG and PrL cortices in AMPH treated rats (ACG: F(1, 21) = 6.837, p = 0.016; PrL: F(1, 21) 
= 4.469, p = 0.047; Table 1). In IL cortex, a main effect of stress was observed (F(1,21) = 
4.941, p = 0.037).   
Among all brain regions examined, the greatest induction of DeltaFosB labeling 
was present in the NAc shell of AAV-BDNF-stressed animals (post-hoc multiple 
comparisons: p ≤ 0.01 for all comparisons, Figure 14A, B), where we observed 
significant main effect of stress (F(1,23) = 26.100, p = 0.001) and AAV-BDNF (F(1,23) = 
39.670, p = 0.001) estimated by two-way ANOVA. Also, significant interaction between 
these two factors (F(1,23) = 10.010, p = 0.004) on DeltaFosB expression was found in NAc 
shell.  In contrast, no difference in DeltaFosB cell counts was observed in the NAc core 
after AMPH challenge in any group (t-test: p > 0.05 for all comparisons; two-way 
ANOVA: behavioral treatment F(1, 22) = 0.110, p = 0.743; virus: F(1, 22) = 0.187, p = 0.743; 
behavioral treatment × virus: F(1, 22) = 1.244, p = 0.277; Table 1).  
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Discussion 
The present results demonstrate that virus-mediated enhancement of VTA BDNF 
expression both extends the time-course of single social defeat stress induced cross-
sensitization to AMPH and facilitates sensitization to a non-sensitizing dosing regimen of 
AMPH in rats exposed to a single episode of social defeat stress. We also show that 
enhancement of VTA BDNF alone is sufficient to increase DeltaFosB expression in 
projection areas of the VTA.   
Our behavioral results are consistent with previous findings (de Jong, Wasilewski, 
et al., 2005) that single social defeat-induced cross-sensitization to AMPH is transient, 
apparent at 3 days but not at 14 days after a single exposure to social defeat. It is 
important to note that handled rats single housed for 14 days showed higher locomotor 
response to AMPH than did handled rats single housed for three days. The increased 
locomotor response to AMPH in drug-naive rats handled/stressed 14 days earlier is likely 
due to the longer period of single-housing, a form of social isolation which can elevate 
rewarding effects of psychostimulants (Deroche, Piazza, Le Moal, & Simon, 1994) and 
can amplify the physiological effect of social defeat (de Jong, van der Vegt, Buwalda, & 
Koolhaas, 2005). In the present study, handled/stressed rats received control virus and 
non-viral treated rats that were single housed for two weeks showed similar locomotor 
responses to AMPH. This suggests that single housing induces an up-ward shift of 
locomotor activity to AMPH, which is consistent across experiments.  
In particular, single social defeat stress-induced cross-sensitization to AMPH was 
not observed 14 days after stress in non-viral treated rats, or in rats that received the 
control GFP virus. The fact that cross-sensitization to AMPH was observed 14 days after 
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single social defeat stress in the presence of enhanced VTA BDNF suggests that BDNF 
prolonged single stress-induced cross-sensitization. However, such an effect should be 
interpreted with caution because persistent VTA BDNF elevation also might alter single 
social stress-induced cross-sensitization at early time points. This possibility remains to 
be investigated. Cross-sensitization and sensitization share the common molecular 
mechanism of enhanced dopamine transmission in mesolimbic circuitry (Imperato, 
Puglisi-Allegra, Casolini, Zocchi, & Angelucci, 1989; P. W. Kalivas & Stewart, 1991), 
and both behaviors represent increased responsiveness of mesolimbic dopaminergic 
neurons to drugs of abuse. In addition, intermittent social defeat stress sensitizes NAc 
dopamine response to cocaine administration (Miczek et al., 2011).  Our data show that 
AAV-mediated VTA BDNF is enhanced in DA neurons, which may directly increase DA 
release (Blochl & Sirrenberg, 1996) and metabolism (Altar et al., 1992). As such, the 
increased number of BDNF expressing dopamine neurons in the rostral VTA could 
enhance mesocorticolimbic dopamine neurotransmission, contributing to the prolonged 
cross-sensitization and the sensitization to AMPH we observed. Our viral infusion 
resulted in increased VTA BDNF in a physiological range similar to the level of VTA 
BDNF in rats exposed to intermittent social defeat stress (Fanous et al., 2010), so it is 
possible that VTA BDNF overexpression induced neuroadaptive changes similar to those 
induced by intermittent social defeat stress to result in sensitized drug response.  
The ability of VTA BDNF to directly modulate sensitization is consistent with the 
finding that infusions of BDNF into the VTA enhance cocaine sensitization (Horger et al., 
1999). Increased endogenous BDNF signaling in the VTA leads to sensitized synaptic 
response in VTA dopamine neurons after cocaine withdrawal (Pu, Liu, & Poo, 2006). 
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BDNF in the VTA may act to titrate the effect of social defeat stress on activating 
mesolimbic neurochemistry by rendering this circuit more vulnerable to stress-induced 
activation. This enhanced vulnerability might then cause the VTA to be more sensitive to 
stress or multiple drug challenges, leading to facilitated sensitization. One mechanism for 
facilitated sensitization may be through amphetamine-induced enhancement of calcium 
signaling, which has been associated with the development of sensitization and produces 
increased BDNF in regions such as the cortex and hippocampus (Brodish & Redgate, 
1973; M. R. Brown et al., 1990; Herman et al., 1989). Calcium signaling specifically in 
the VTA is important in the development of psychostimulant sensitization (Herman et al., 
1989). The presence of increased VTA BDNF may therefore facilitate prolonged synaptic 
plasticity in the face of a stimulus that produces calcium release (but whose magnitude 
would not normally result in such prolonged plasticity, such as a single administration of 
amphetamine). In this way, enhanced VTA BDNF may be considered a possible “risk 
factor” for development of neuronal and behavioral drug sensitization, which may 
interact with factors such as stress to further increase “risk.”  This agrees with the role 
mesolimbic BDNF has been hypothesized to play in addictive behavior (Baxter & 
Rousseau, 1979).  
Intermittent social defeat stress resulted in prolonged BDNF elevation in the VTA 
(Fanous et al., 2010) and DeltaFosB accumulation in the projection areas of the VTA 
(Nikulina et al., 2008). In the present study, we found that VTA BDNF overexpression 
alone was sufficient to induce DeltaFosB accumulation in the NAc and PFC. This finding 
indicates that persistent elevation of VTA BDNF leads to DeltaFosB accumulation, 
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whose mechanism may be similar to DeltaFosB elevation observed after repeated social 
defeat stress.   
DeltaFosB accumulation in the NAc could represent a homeostatic mechanism to 
balance increased VTA BDNF associated with social defeat, as DeltaFosB in the NAc 
can enhance the resilience of animals to the aversive effects of chronic social defeat stress 
(Vincent Vialou et al., 2010). The effect of a single episode of social defeat stress alone is 
too transient to induce considerable DeltaFosB accumulation in the NAc shell in rats 
receiving AAV-GFP. However, in the presence of VTA BDNF overexpression, a single 
defeat stress-induced neuroadaptation may persist, and transcriptional activation of 
DeltaFosB may be prolonged in the NAc shell. The mechanism underlying increased 
DeltaFosB accumulation in terminal regions resulting from VTA BDNF overexpression 
requires further investigation.  
As discussed above, VTA BDNF overexpression significantly increased 
DeltaFosB expression in the PFC and the NAc of handled drug-naïve rats. However, 
repeated AMPH challenges to AAV-BDNF- stressed rats induced a significant increase 
of DeltaFosB expression in the NAc shell, but not in the NAc core and PFC, and this 
effect was region-specific. The explanation for this effect on DeltaFosB expression is 
likely the differential responsiveness of different regions to stress- and drug-related 
stimuli. This is supported by data demonstrating different anatomical connections and 
biochemical characteristics of the NAc core and shell (Zahm, 2000), and as such the 
subregions may mediate distinct functions related to motor and motivation (Craddock, 
1978). Furthermore, recent research indicates regionally specific effects of BDNF 
signaling in NAc core and shell in drug seeking (X. Li et al., 2013). Also DeltaFosB 
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modulates synaptic plasticity and reward-related behaviors in a sub-region and cell-type 
specific manner in the NAc core and shell (Grueter, Robison, Neve, Nestler, & Malenka, 
2013). Although the involvement of PFC in the sensitization to AMPH is well identified 
(Fanous et al., 2012), no further DeltaFosB increase was observed in AAV-BDNF- 
stressed rats after AMPH injections in the PFC. It is possible that DeltaFosB in PFC is 
not susceptible to AMPH in rats with BDNF overexpression in the VTA, at least at the 
time-point we observed.  Therefore, DeltaFosB expression may vary in different 
mesocorticolimbic regions in response to the same stimulation (drugs and stress), which 
may underlie why the current data reflect a distinct trend of increased DeltaFosB 
expression only in NAc shell.  
In conclusion, rats with higher VTA BDNF levels developed prolonged AMPH 
cross-sensitization and sensitization to non-sensitizing dosing regimen of AMPH after 
social defeat stress. This was associated with increased DeltaFosB expression in the NAc 
shell. The present findings suggest that the elevated VTA BDNF could be a risk factor 
that amplifies vulnerability for drug abuse triggered by socially aversive stimuli. 
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Chapter 3  
KNOCKDOWN OF TRKB RECEPTOR EXPRESSION IN THE NAC SHELL 
PREVENTS INTERMITTENT SOCIAL DEFEAT STRESS-INDUCED CROSS-
SENSITIZATION TO AMPHETAMINE IN RATS 
 
Abstract 
The nucleus accumbens (NAc) is a critical region for the rewarding effects of 
drugs of abuse. Brain-derived neurotrophic factor (BDNF) can facilitate stress- and drug-
induced neuroadaptation in the mesocorticolimbic system. BDNF-containing afferents to 
the NAc originate from the ventral tegmental area (VTA) and the prefrontal cortex; 
BDNF release activates neurotrophin tyrosine kinase receptor type 2 (TrkB). In this study, 
we examined the necessity of BDNF-TrkB signaling in NAc shell during social defeat 
stress-induced cross-sensitization to amphetamine. Adeno-associated virus expressing 
short hairpin RNA directed against TrkB (AAV-shTrkB) was infused bilaterally into the 
NAc shell to knockdown TrkB, while AAV-GFP was used as the control virus. Rats were 
exposed to intermittent social defeat stress or handling procedures; amphetamine 
challenge was given ten days after the last defeat and locomotor activity was measured. 
Stressed rats that received control virus showed cross-sensitization to amphetamine 
compared to the handled rats. In contrast, NAc TrkB knockdown prevented social defeat 
stress-induced cross-sensitization. TrkB knockdown in the NAc was found to reduce 
phospho-extracellular signal-regulated kinase (ERK) expression in this region. Together 
with this, NAc TrkB knockdown also prevented stress-induced elevation of BDNF and 
GluA1 subunit of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
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receptor in the VTA and as well as DeltaFosB expression in the NAc. These findings 
indicate that NAc BDNF-TrkB signaling is required for social defeat stress-induced 
cross-sensitization. NAc TrkB-BDNF signaling also appears to be involved in the 
regulation of GluA1 in the VTA, in addition to NAc DeltaFosB accumulation that could 
trigger cross-sensitization after social defeat stress.   
Introduction 
 Stress augments drug-induced mesolimbic dopamine transmission and locomotor 
activity (Sorg & Kalivas, 1991; Jasmine J. Yap & Klaus A. Miczek, 2008), known as 
cross-sensitization. Among all types of stressors, social defeat has face validity to 
replicate aversive social interaction and personal failure in humans (Koolhaas, Meerlo, de 
Boer, Strubbe, & Bohus, 1997), and induces long-lasting cross-sensitization to 
psychostimulants (H. E. Covington, 3rd & Miczek, 2001; Nikulina et al., 2004). After 
intermittent social defeat stress, elevation of brain-derived neurotrophic factor (BDNF) 
expression in the ventral tegmental area (VTA) was observed with a time course similar 
to that of cross-sensitization to psychostimulants (Fanous et al., 2010), and enhanced 
VTA BDNF signaling was found to potentiate cross-sensitization to AMPH (J. Wang et 
al., 2013). In the mesolimbic circuit, BDNF is synthesized in VTA dopamine neurons and 
transported anterogradely to the nucleus accumbens (NAc; (Altar et al., 1997)), the brain 
region mediating addictive effects of drugs of abuse. Enhanced BDNF signaling in the 
NAc facilitates the development of sensitization to cocaine (Horger et al., 1999). Also, 
NAc TrkB overexpression enhances sensitization to cocaine, which can be prevented by 
overexpression of the dominant negative form of TrkB (Bahi et al., 2008; Crooks, Kleven, 
Rodriguiz, Wetsel, & McNamara, 2010). BDNF-induced activation of TrkB receptors 
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triggers several downstream signaling pathways (Minichiello, 2009), among which the 
extracellular signal-regulated protein kinase (ERK) pathway in the NAc was found to be 
involved in sensitization to psychostimulants (Kim, Shin, Yoon, & Kim, 2011; Mattson et 
al., 2005).   
 Social defeat stress-induced cross-sensitization to psychostimulants is 
concomitant with increased expression of the GluA1 subunit of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptor in the VTA (H. E. Covington, 3rd, 
Tropea, Rajadhyaksha, Kosofsky, & Miczek, 2008). In contrast, AMPA receptor 
blockade in the VTA prevents sensitization to psychostimulants (Y. Li, Vartanian, White, 
Xue, & Wolf, 1997). Therefore elevation of GluA1 expression in the VTA may 
contribute to the stress induced cross-sensitization.  
 DeltaFosB, a truncated variant of FosB, is induced in the NAc by chronic 
exposure to many drugs of abuse (Nestler, 2008). After repeated social defeat stress, 
DeltaFosB expression and its co-localization with BDNF were increased in the NAc 
(Nikulina et al., 2004; Perrotti et al., 2004).  BDNF immunoreactivity in this region could 
be exogenous BDNF from afferents to the NAc. Also, elevated DeltaFosB in the NAc 
shell accompanies augmentation of the stress induced cross-sensitization induced by 
VTA BDNF overexpression (J. Wang et al., 2013). Furthermore, NAc DeltaFosB 
overexpression induces sensitization to cocaine (Kelz et al., 1999), possibly through 
regulation of genes involved in drug-induced neuroplasticity (McClung & Nestler, 2003). 
Thus, the presence of DeltaFosB in the NAc can be used as a marker for enhanced 
sensitivity to the rewarding effect of drugs of abuse.   
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 The present study investigated the effect of NAc BDNF signaling in social defeat 
stress-induced cross-sensitization. We used adeno-associated virus-mediated gene 
transfer to deplete the TrkB level in the NAc by overexpression of short hairpin RNA 
directed against TrkB. To identify the factors associated with social defeat stress-induced 
cross-sensitization and potentially affected by BDNF signaling in mesolimbic circuit, 
such as BDNF, GluA1 in the VTA and phospho-ERK1/2, DeltaFosB in the NAc, were 
also measured to further characterize the molecular substrates of social defeat stress-
induced cross-sensitization.     
Material and Methods   
Animals  
Subjects were male Sprague Dawley rats (Charles River Laboratories, Hollister, 
CA, USA), weighing 225–250 g upon arrival, which were single-housed in 25×50×20 cm 
cages under a reverse light/dark cycle (12 h: 12 h, lights off at 0900 h) with unlimited 
access to food (Purina Rodent Diet, Brentwood, MO, USA) and water. Male Long-Evans 
rats (Charles River), termed “residents,” were pair-housed with females in 37×50×20 cm 
cages. Residents were screened for aggressive behavior as described previously (Nikulina 
et al., 2004). All experimental procedures were approved by the Arizona State University 
Institutional Animal Care and Use Committee, and conducted in accordance with the 
Guide for the Care and Use of Laboratory Animals (National Research Council, 1996). 
All efforts were used to minimize suffering and to limit the number of animals used.  
Viral vector 
Pseudotyped AAV2/10 vectors were used in all experiments. An AAV2/10 
rep/cap plasmid from the U Penn Vector Core facility provided the AAV2 replicase and 
 69 
AAV10 capsid genes (Gao et al., 2002), while adenoviral helper functions were supplied 
by the pHelper plasmid (Stratagene, La Jolla, CA). The vector plasmids contained either 
of two different shRNA under control of a murine U6 promoter. The shRNA target 
sequences were as follows: TGGAGTTGACTATGAGACAAA and 
CCACGGATGTTGCTGACCAAA. Each AAV vector containing a shRNA also 
included an upstream eGFP indicator gene cassette flanked by a viral CMV-IE promoter 
and an SV40 intron/polyA sequence. A mixture of viral vectors containing the two 
shRNA was used to achieve maximum trkb mRNA knockdown. A similarly packaged 
and otherwise isogenic AAV–eGFP plasmid with no shRNA was used as a control virus. 
A standard triple transfection protocol was used to generate the helper-free pseudotyped 
AAV2/10 vectors, as previously described (Xiao et al., 1998). Briefly, the three plasmids 
were co-transfected into HEK-293 cells (Stratagene, La Jolla, CA) via calcium phosphate 
precipitation. Cells were harvested 48 h later, resuspended in DMEM, freeze-thawed with 
a dry ice-ethanol slurry three times and centrifuged at 13,000 rpm for 10 min to produce a 
clarified cell lysate. The resulting viral stocks were stored at -80°C prior to use.  
Intracranial viral infusion   
After one week of acclimation to the environment, rats were anesthetized with 
isoflurane and positioned in a stereotaxic frame (Leica Angle Two; Richmond, IL). Burr 
holes were drilled bilaterally at stereotaxic coordinates: AP: +2.0 mm; ML: ±1.1 mm 
from the bregma (Paxinos G & 2007), and a Hamilton syringes with 24 gauge flat 
injector tip (Hamilton; Reno, NV) were lowered through the holes to reach the NAc shell 
(DV: −7.8 mm); 0.5 µl of purified virus) was infused into the NAc shell bilaterally at a 
speed of 0.05 µl/min. After infusion, the syringes remained at the infusion site for 5 min 
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to prevent retrograde filling of the virus along the infusion tract.. AAV-10-mediated 
transgene overexpression achieves maximum expression in 1-2 weeks, and lasts at least 
three month after transfection (Klein et al., 1998). This vector does not possess the 
sequence encoding capsid proteins, so it cannot disseminate beyond the transfection site. 
Behavioral treatments began two weeks after surgery to allow complete recovery and 
viral expression.  
Social defeat stress 
Social defeat stress consisted of a short exposure to aggressive behavior of a 
resident rat, described in detail previously (Nikulina et al., 2012). Each resident rat was 
group housed with one female rat for at least two weeks before beginning the experiment. 
After removing the female, the experimental intruder rat was placed into the resident’s 
home cage under a stainless steel mesh protective cage (15×25×15 cm) for 5 min. The 
protective cage was then removed, and the resident displayed aggressive behavior toward 
the intruder for 2-5 min until “defeat” occurred, demonstrated by the intruder exhibiting a 
supine posture for at least 4 s. Further physical contact was then prevented by placing the 
intruder under the protective cage for an additional 15 min before returning to its home 
cage. Control rats were handled and weighed on the days their counterparts were defeated 
and weighed. 
Validation of AAV-shTrkB induced TrkB knockdown  
One week after arrival, rats received intra-NAc shell viral infusion of AAV-GFP 
or AAV-shTrkB (n = 6). After surgery, rats were single housed for 35 days without any 
behavioral treatment, and then perfused transcardially to examine the efficacy of AAV-
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shTrkB-mediated TrkB knockdown by immunohistochemistry. A time line for validation 
of viral effects is presented in Figure 15. A.  
Experimental design 
Rats were randomly separated into four groups based on two factors: viral vector 
(AAV-GFP vs. AAV-shTrkB) and behavioral treatment (handling vs. intermittent social 
defeat stress). Therefore, the groups were: AAV-GFP-handled (n = 7), AAV-GFP-
stressed (n = 8), AAV-shTrkB-handled (n = 8), and AAV-shTrkB-stressed (n = 8). 
Following surgical recovery, rats were exposed to intermittent social defeat stress four 
times in ten days or were handled according to the same schedule. Ten days after the last 
defeat, locomotor activity was assessed in all rats after saline or AMPH injection. Three 
rats were excluded from this study due to the occasional presence of video artifacts 
during tracking. All rats were euthanized one week later, 41 days after viral infusion 
surgery, as shown on the time line in Figure 16.A. In subsequent processing of brain 
tissue, sample number varied slightly across different procedures and different brain 
regions due to the exclusion of samples with artifacts during tissue collection or 
processing.  
Locomotor tracking  
Ten days after the last social defeat or handling procedure, rats were placed into 
the locomotion tracking area in their home cages to acclimate to the novel environment 
for one hour per day for two consecutive days, and 0.9% saline injection (1.0 ml/kg, i.p.) 
was given to habituate rats to injection. On the third day, locomotor activity was 
measured using Videotrack (Viewpoint Life Sciences; Montreal, Quebec, Canada). Rats 
first acclimated to the testing environment for 30 min, during which baseline locomotor 
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activity was measured. Rats then received a saline injection (1.0 ml/kg, i.p) followed by 
locomotor tracking for 40 min, and AMPH (1.0 mg/kg, i.p.) challenge followed by 
locomotor tracking for 70 min. Based on prior research, the dose of AMPH used in the 
present study produces mainly large ambulatory movements (Geyer et al., 1987), so total 
distance of large ambulatory movements (greater than 10 cm) measured in 10 min bins 
was used as an indicator of the extent of behavioral sensitization in response to AMPH . 
Peak locomotor activity was achieved during the 10 to 50 min period after AMPH 
injection.  
Perfusion and tissue processing 
Rats used for validation of viral vector were deeply anesthetized with sodium 
pentobarbital (100 mg/kg) and perfused transcardially with 10 ml of 10% heparin in 
0.1 M phosphate-buffered saline (pH 7.4), followed by 250 ml of 4% paraformaldehyde 
in 0.1 M phosphate buffer (pH 7.4). Brains were post-fixed for 1.5 h in the same fixative 
at 4°C, soaked in 12.5% sucrose, then in 25% sucrose in 0.1 M PBS at 4°C until they 
sank to the bottom of the solution for each concentration. Coronal brain sections (20 μm) 
were collected in a -22°C cryostat, and thaw-mounted onto glass slides (Superfrost Plus; 
Fisher; Waltham, MA). NAc sections were collected from +1.8 to +0.8 mm from bregma.   
Fresh frozen tissue collection 
After locomotor sensitization assessment, rats were deeply anesthetized with 
sodium pentobarbital (100 mg/kg) and decapitated; brains were removed and frozen for 
15 sec in 2-methylbutane at -70°C. Brains were sectioned in a -22°C cryostat to reach the 
level of the NAc, where 2.0 mm diameter tissue punches were removed centered on the 
coordinates: AP: 1.8 mm; DV: -7.0 mm ; ML: 1.3 mm. Similarly,1.0 mm diameter tissue 
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punches were taken from the VTA centered on the coordinates: AP: -5.0 mm; DV: -
8.8mm ; ML: 0.8mm (Paxinos G & 2007). The depth of each punch was limited to 1.0 
mm. Brain tissue was lysed in 1×RIPA buffer (9806, Cell signaling Technology, Beverly, 
MA), with protease inhibitor (P8340, Sigma) and phosphatase inhibitor (P8340, Sigma), 
heated at 37°C for 20 min, then sonicated at 4°C for 1 sec, and centrifuged at 14,000 g for 
10 min. The supernatant was collected, and total protein concentration was determined 
using a BCA protein assay kit (Pierce-Thermo Scientific, Waltham, MA).      
Immunohistochemistry and image analysis 
Sections on slides were washed extensively in 0.05 M potassium phosphate-
buffered saline (KPBS), then blocked for 1 h in 10% normal goat serum and 0.4% Triton 
X-100 in 0.05 M KPBS. Sections were then incubated with primary antibody: TrkB 
(1:1,000; cat. #4606, Cell Signaling Technology, Beverly, MA) for 48 h. Slides were then 
washed in 0.05 M KPBS and incubated in biotin-conjugated goat anti-rabbit serum for 1 
h (1:200 dilution in blocking solution, Vectastain ABC kit; Vector Laboratories; 
Burlingame, CA). After washing in 0.05 M KPBS, sections were incubated with avidin–
biotin–peroxidase complex for 1 h, then washed again and developed using DAB 
chromogen with nickel intensification (DAB Peroxidase Substrate kit, Vector 
Laboratories). After dehydration in graded concentrations of ethanol and xylene, 
coverslips were applied. 
Tissue sections were examined for the presence of chromogen reaction products 
using a Zeiss Axioskop microscope with 20× or 40× objectives; selected areas were 
captured and digitized using a color digital video camera (MBF Biosciences; Williston, 
VT) interfaced to the microscope. A cell profile was considered labeled if its pixel 
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intensity was more than 2 standard deviations greater than the background, as calculated 
by Stereo Investigator software (MBF Biosciences). At least three adjacent sections were 
analyzed for each brain region per animal, and labeling density was calculated by 
dividing the estimated total number of labeled profiles by the total area analyzed.   
Western blotting 
Samples (~30 μg of total protein/lysate) were loaded and electrophoresed on 4–20% 
gradient precast polyacrylamide gel (Bio-Rad, Hercules, CA) under reducing conditions, 
and proteins were transferred onto supported nitrocellulose membranes (0.2 µm pore size) 
for immunoblotting (Bio-Rad, Hercules, CA). Membranes were washed in 1× TBS-
Tween 20 (pH 7.4) (TBS-T)  3 X 5 min, and blocked with 5% non-fat dry milk in TBS-T 
for 1 h at room temperature. Membranes were then incubated overnight at 4°C with 
antibodies to BDNF (1:1,000; #sc-546, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 
FosB (1:1,000; #sc-48, Santa Cruz Biotechnology), TrkB (1:1,000; #4606, Cell Signaling 
Technology, Beverly, MA), ERK (1:1,000; #4695, Cell Signaling Technology), phospho-
ERK (1:1,000; #4370S, Cell Signaling Technology), GluA1 (1:1,000; #MAB2263, 
Millipore; Temecula, CA) or β-actin (1:5,000; #A5441, Sigma). Extensive washing with 
TBS-T solution was accomplished at each step. Membranes were incubated for 120 min 
with IRDye®800 CW Goat anti-Mouse IgG1 (1:10,000; LI-COR, Lincoln, NE) for two 
hours, or with biotin-conjugated anti-rabbit or anti-mouse IgG for one hour (1:500; 
Vector, Burlingame, CA), then immersed in IRDye®680 streptavidin (1:5,000; Lincoln, 
NE) for one hour, depending on the antibody. The fluorescence signal bands were 
scanned using the Odyssey FC quantitative fluorescence imaging system (LI-COR, 
Lincoln, NE), and further analyzed using LI-COR Image Studio.  
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Data analysis 
Viral efficacy was validated by counting of immunolabeled cells and analyzed 
with one-way ANOVA (viral vector as the between-subjects factor). Two-way ANOVA 
with viral vector and behavioral treatment as between-subjects factors was used to 
analyze locomotor response to AMPH during the peak locomotor response period, and 
the intensity of bands in western blots. To examine whether the significant main effect of 
stress on locomotor response to AMPH and on gene expression in groups received AAV-
GFP were prevented by TrkB knockdown, planned contrast comparison was used 
(Keppel, 1991). All data are reported as mean ± SEM, and all significance levels were set 
at p ≤ 0.05. 
Results  
AAV-shTrkB-induced TrkB knockdown in the NAc shell 
We examined the efficacy of AAV-shTrkB induced TrkB knockdown in the NAc 
shell 35 days after viral infusion (Figure 15.A and B). TrkB expression level in the NAc 
shell was significantly reduced in rats that received AAV-shTrkB compared to rats that 
received AAV-GFP control virus, measured by IHC ( F(1, 11) =10.662,  p=0.008; Figure 
15.C and D). 
TrkB knockdown in the NAc shell prevents intermittent social defeat induced 
cross-sensitization to AMPH 
  AMPH challenge (1.0 mg/kg, i.p.) was given ten days after the last episode of 
intermittent social defeat stress. Baseline and saline-induced locomotor activity was 
similar among the groups. Significantly higher locomotor activity was found after AMPH 
in AAV-GFP-stressed rats in comparison with in AAV-GFP-handled rats and AAV-
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shTrkB-stressed rats during the peak locomotion period (10 to 50 min after AMPH 
administration, planned comparison, F(1,11) = 4.64, p = 0.042, F(1,11) = 10.04, p = 0.004 ). 
In contrast, no difference in locomotor activity in response to AMPH challenge was 
found between AAV-shTrkB-stressed rats and AAV-shTrkB-handled rats (F(1,12) = 0.19, p 
= 0.664). A significant main effect of the virus was also found during peak locomotion 
period (10 to 50 min after AMPH challenge) in two-way ANOVA (F(1,23) = 7.262, p = 
0.013; Figure 16.C). In addition, locomotor activity in AAV-GFP-stressed rats was 
significantly higher than in AAV-GFP-handled, AAV-shTrkB-handled, and AAV-
shTrkB-stressed (t-test: p = 0.029, p = 0.014, p = 0.012 respectively; Figure 16.B)  
TrkB knockdown reduces phospho-ERK in the NAc  
Examined seventeen days after the last social defeat stress, neither intermittent 
social defeat stress nor TrkB knockdown had any significant effect on total ERK 
expression in the NAc (two-way ANOVA: stress: F (1, 26) = 0.274, p = 0.605; TrkB 
knockdown: F (1, 26) = 3.219, p = 0.084; stress × TrkB knockdown: F (1, 26) = 0.106, p = 
0.747; Figure 17.A). In contrast, phospho-ERK in the NAc was significantly reduced by 
NAc TrkB knockdown, as indicated by the significant main effect of AAV-shTrkB from 
two-way ANOVA (F (1, 26) = 12.851, p = 0.001; Figure 17.B). However, no effect of stress 
on phospho-ERK was observed at this time point (F (1, 26) = 0.591, p = 0.449).   
TrkB knockdown in the NAc shell prevents intermittent social defeat induced 
increase of BDNF and GluA1 in the VTA 
Intermittent social defeat stress resulted in a significant increase of BDNF 
expression in the rostral VTA of rats that received the control AAV-GFP virus, examined 
seventeen days after the last defeat (F (1, 12) = 10.52, p = 0.003; Figure 18.A). In contrast, 
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with TrkB knockdown in the NAc shell, no difference on VTA BDNF expression was 
found between handled and stressed rats (F (1, 13) = 2.99, p = 0.096). Also, a significant 
main effect of stress and a significant interaction between two factors on VTA BDNF 
expression were found (two-way ANOVA: stress: F (1, 26) = 5.03, p = 0.034; stress × TrkB 
knockdown: F (1, 26) = 6.335, p = 0.018), but no main effect of TrkB knockdown was 
observed (F (1, 26) = 0.01, p = 0.983).    
Significant main effects of stress and virus on VTA GluA1 expression were 
observed (two-way ANOVA, stress: F (1, 26) = 4.456, p = 0.045; TrkB knockdown: F (1, 26) 
= 19.613, p = 0.001; Figure 18.B). Intermittent social defeat stress-induced an increase of 
GluA1 subunit of AMPA receptor expression in the VTA of rats received control AAV-
GFP virus (F (1, 12) = 6.80, p = 0.015) and AAV-shTrkB-stressed rats (F (1, 13) = 20.45, p = 
0.001). In contrast, intermittent social defeat induced increase of GluA1 in the VTA was 
not found in rats with NAc shell TrkB knockdown (F (1, 14) = 3.42, p = 0.076).  
NAc shell TrkB knockdown reduces the intermittent social defeat stress-
induced DeltaFosB expression in the NAc  
 Intermittent social defeat stress significantly increased DeltaFosB expression in 
the NAc of rats that received control AAV-GFP virus compared to AAV-GFP-handled 
rats ( F (1, 13) = 6.60, p = 0.016) and AAV-shTrKB-stressed rats (F (1, 13) = 18.09, p = 
0.001). However, no difference in DeltaFosB expression levels in the NAc was found 
between AAV-shTrkB-handled and AAV-shTrkB-stressed rats ( F (1, 13) = 0.001, p = 
0.948). A significant main effect of stress and a significant interaction between two 
factors were found (two-way ANOVA, stress: F(1,26) = 8.725, p = 0.007; TrkB knockdown: 
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F(1,26) = 0.601, p = 0.445; stress × TrkB knockdown: F(1,26) = 8.166, p = 0.008; Figure 
18.C).  
Discussion 
The present study examined the necessity of BDNF-TrkB signaling in the NAc 
shell in social defeat stress-induced cross-sensitization to psychostimulants. By reducing 
the expression of TrkB in the NAc shell with AAV-shTrkB mediated knockdown, 
intermittent social defeat stress- induced cross-sensitization to AMPH was prevented. Of 
note, social defeat stress-induced key neurochemical changes in the mesolimbic circuit 
were also prevented and levels of activation of downstream of BDNF-TrkB signaling 
associated with cross-sensitization to psychostimulants were reduced in the NAc.   
BDNF signaling in the NAc shell is necessary for the development of social 
defeat stress- induced cross-sensitization 
Based on previous research, NAc is the pivotal brain nucleus mediating the 
rewarding effects of drugs of abuse and the expression of behavioral sensitization (Cador, 
Bjijou, & Stinus, 1995). Both stress and drugs of abuse increase dopamine transmission 
in the NAc (Garcia-Keller et al., 2013; Miczek, Mutschler, et al., 1999; Saal et al., 2003), 
which underlies the sensitized psychomotor response to the drugs of abuse. NAc is 
composed of shell and core, two anatomically and functionally distinctive subregions 
which have different afferent and efferent projections (Bahi et al., 2008; A. Y. Deutch & 
Cameron, 1992) and different functions in addiction related behaviors (Berton et al., 
2006). Drugs of abuse preferentially increase dopamine levels in the shell, as opposed to 
its core counterpart (Pontieri, Tanda, et al., 1995; Tanda, Pontieri, & Di Chiara, 1997; 
Zocchi et al., 2003). The NAc shell is also more responsive to stress than the core in 
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terms of dopamine transmission (P. W. Kalivas & Duffy, 1995). Therefore, the NAc shell 
is the possible anatomical substrate underlying social defeat stress- induced cross-
sensitization. 
 Long-lasting BDNF elevation was observed in the VTA following repeated 
social defeat stress, which is accompanied by persistent cross-sensitization to AMPH 
(Fanous et al., 2010; Nikulina et al., 2004). Overexpression of BDNF in the VTA 
engenders prolonged cross-sensitization and elevation of DeltaFosB in the NAc shell in 
stressed rats (J. Wang et al., 2013). These findings indicate that increased BDNF 
signaling in the mesolimbic circuit can potentiate stress induced cross-sensitization and 
that the NAc shell may be the one of the action sites of mesolimbic BDNF signaling 
during this potentiation. Our behavioral results demonstrate that BDNF signaling via 
TrkB receptors in the NAc shell is necessary for the development of cross-sensitization.  
Stress-induced neurochemical alterations are prevented by TrkB knockdown in 
the NAc shell  
Drugs of abuse can increase the levels of phospho-ERK in multiple regions of 
brain reward pathways (Berhow et al., 1996; Valjent, Pages, Herve, Girault, & Caboche, 
2004), and ERK activation in various brain regions plays an important role in 
psychomotor sensitization and mediates the rewarding effects of drugs of abuse (Girault, 
Valjent, Caboche, & Herve, 2007; Lin Lu et al., 2005; L. Lu, Koya, Zhai, Hope, & 
Shaham, 2006). Therefore, an elevated level of phospho-ERK in the NAc may enhance 
the reinforcing and sensitizing effects of drugs of abuse. In addition, elevated ERK 
phosphorylation can be observed immediately after stress (Iniguez et al., 2010). It is 
possible that the elevated level of phospho-ERK in the NAc shell after social defeat stress 
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is critical for the development of cross-sensitization to psychostimulants and it is also 
possible that the persistent reduction of phospho-ERK in the NAc of rats that received 
TrkB knockdown could disrupt this same process. Also, the reduction of phospho-ERK in 
the NAc is a feature of resilience to social defeat stress (V. Krishnan et al., 2007). 
Therefore, rats with TrkB knockdown resulting in a reduction of phospho-ERK in the 
NAc could be more resilient to the aversive effects of social defeat stress and show 
attenuated stress-induced cross-sensitization. However, the molecular mechanism of the 
involvement of phospho-ERK in the NAc during the cross-sensitization, especially the 
downstream factors activated by phospho-ERK, remains to be characterized.  
Elevation of BDNF in the VTA is one of the hallmark neurochemical changes that 
takes place after intermittent social defeat stress. However, the increase in BDNF is not 
obvious immediately after the stress exposures, but only becomes significant weeks after 
stress (Fanous et al., 2010). Together with results of the present study, these data suggest 
that TrkB-BDNF signaling onto the NAc shell involves stress-induced BDNF expression 
in the VTA. 
Notably, BDNF can up-regulate the total cellular levels of AMPAR subunits 
GluA1–GluA4 (Caldeira et al., 2007). The AMPARs are tetramers comprised of four 
glutamate receptor subunits (GluA1-GluA4). GluA2 lacking AMPARs are Ca2+ 
permeable (CP-AMPAR), and therefore exhibit increased conductance and potentiated 
synaptic neurotransmission relative to GluA2 containing AMPARs (Burnashev, Monyer, 
Seeburg, & Sakmann, 1992). BDNF can enhance synaptic strength via the synaptic 
delivery of newly synthesized GluA1 subunits as CP-AMPARs (Fortin et al., 2012). The 
elevation of VTA GluA1 was involved in the sensitization to psychostimulants and 
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addiction and the level of homomeric GluA1 receptors was increased in the VTA of 
cocaine-sensitized rats (Carlezon & Nestler, 2002; P. W. Kalivas, 2009). Several lines of 
evidence show that stress exposure increases synthesis and membrane trafficking of 
AMPA-sensitive glutamate receptor subunits in dopaminergic neurons of the VTA, thus 
increasing the strength at excitatory synapses on dopamine neurons post-synaptically (H. 
E. Covington, 3rd et al., 2008; Fitzgerald, Ortiz, Hamedani, & Nestler, 1996). Therefore, 
we further examined GluA1 expression in the VTA, a target up-regulated by BDNF and 
involved in synaptic plasticity during psychostimulant/stress-induced sensitization. Our 
results showed that stress-induced increases of BDNF and GluA1 in the VTA are 
concomitant with stress-induced cross-sensitization to psychostimulants and that TrkB 
knockdown in the NAc shell significantly attenuated GluA1 expression. Considering the 
regulatory role of BDNF on GluA1 expression, our finding also suggests VTA BDNF 
might be the permissive factor required for GluA1 elevation in the VTA induced by 
social defeat stress. 
 The long-term effects of intermittent social defeat stress, in terms of cross-
sensitization, suggest the involvement of long-lasting changes on gene expression. 
Repeated exposure to virtually all types of drugs of abuse and stressors induce DeltaFosB 
expression in the NAc (J. Chen, Kelz, Hope, Nakabeppu, & Nestler, 1997; Nestler, 2008; 
Nikulina et al., 2008; Perrotti et al., 2004), which progressively accumulates and persists 
for at least several weeks after the cessation of drug/stress exposure due to its unusual 
stability (Nestler, 2008). Overexpression of DeltaFosB in dynorphin-containing neurons 
within the NAc induces sensitized responses to drugs of abuse (Zachariou et al., 2006), 
and DeltaFosB in the NAc mediates the natural reward induced cross-sensitization to 
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AMPH (Pitchers et al., 2013). DeltaFosB can regulate many genes involved in chronic 
drug exposure induced neuroplasticity in the reward circuitry (McClung & Nestler, 2003). 
Stress-induced accumulation of DeltaFosB in the NAc could therefore change the 
transcription potential of many target genes, which may prime the brain reward circuit to 
the rewarding and sensitizing effects of drugs of abuse. Furthermore, higher co-
localization of BDNF and DeltaFosB was found after intermittent social defeat stress in 
the projection areas of the mesocorticolimbic circuit, including the NAc (Nikulina et al., 
2012), and VTA BDNF overexpression together with single social defeat stress 
specifically increased DeltaFosB in the NAc shell (J. Wang et al., 2013). In the current 
study, both elevation of BDNF in the VTA and accumulation of DeltaFosB expression in 
the NAc shell were prevented by TrkB knockdown in the NAc shell, which suggests that 
these two neurochemical changes in the mesolimbic circuit are gated by TrkB mediated 
signaling. Our finding also implicates a potential causative interaction between BDNF-
TrkB signaling and expression of DeltaFosB in the NAc shell, which remains to be 
investigated. 
In conclusion, BDNF-TrkB signaling in the NAc is critical for social defeat stress 
induced neuroadaptive changes that are necessary for cross-sensitization to 
psychostimulants. Phospho-ERK levels were significantly reduced by TrkB knockdown 
and the active form of ERK is a part of the intracellular pathways for BDNF, dopamine, 
and glutamate, all of which were found to be involved in the behavioral effect of 
psychostimulant action (L. Lu et al., 2006; Valjent et al., 2005). Therefore, BDNF-TrkB 
signaling onto the NAc shell might be a key factor that employs various signaling 
mechanisms and mediates cross-sensitization following social defeat stress. TrkB 
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receptors in the NAc-shell could be a novel therapeutic target for prevention of stress-
induced vulnerability to drugs of abuse. 
 
Chapter 4  
BDNF OVEREXPRESSION IN THE VENTRAL TEGMENTAL AREA 
POTENTIATE EPISODIC SOCIAL DEFEAT STRESS-INDUCED ESCALATION 
OF COCAINE SELF-ADMINISTRATION 
 
Abstract 
 Brain-derived neurotrophic factor (BDNF) is a neural growth factor which can 
enhance the survival and activity of dopaminergic neurons and is involved in synaptic 
plasticity. BDNF is elevated in several portions of the mesocorticolimbic circuit, such as 
the ventral tegmental area (VTA) after exposure to psychostimulants or intermittent 
social defeat stress, and can mediates sensitivity to cocaine. Intermittent exposure to 
social defeat stress escalates drug intake during self-administration in rats. We 
hypothesized that BDNF overexpression in the VTA will further potentiate stress-induced 
escalation of cocaine intake. Adult male Sprague-Dawley rats were implanted with 
intravenous jugular catheters and received bilateral infusion of an adeno-associated viral 
vector (AAV) containing cDNA of green fluorescent protein (AAV-GFP) or bdnf (AAV-
BDNF) into the VTA. Rats were exposed to either intermittent social defeat stress (4 
defeats over 10 days) or handling. One week after the last defeat, all rats (GFP-handled, 
GFP-stressed, BDNF-handled, BDNF-stressed) were trained to self-administer cocaine 
(0.75 mg/kg/0.1ml, i.v.) under fixed ratio (FR) schedules of reinforcement. After self-
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administration (SA) stabilized on an FR5 schedule, rats were subjected to three 
progressive ratio (PR) sessions (0.375 mg/kg) on alternating days with maintenance 
sessions (0.75 mg/kg) on an FR5 schedule. The day after the last maintenance session, 
rats were given 12-h access to cocaine (0.375 mg/kg) on an FR5 schedule (12-h binge). 
Ten days after binge session, brains were removed and processed for 
immunohistochemistry. Facilitated acquisition of cocaine SA was found in BDNF-
handled group compared to AAV-GFP-handled group. The BDNF-stressed group showed 
the highest level of drug intake during the 12-h binge and the greatest BDNF expression 
in the VTA. We also found a positive correlation between VTA BDNF level and drug 
intake during the 12-h binge. VTA BDNF overexpression significantly reduced BDNF in 
the prelimbic cortex (PrL) and prevented stress-induced BDNF increase in PrL. Also 
VTA BDNF overexpression resulted in greater DeltaFosB accumulation in both the shell 
and core of the NAc than did AAV-GFP after cocaine SA. Our results suggest that the 
level of BDNF in the VTA may titrate compulsive drug-taking behavior, and that higher 
VTA BDNF is a risk factor engendering greater vulnerability to cocaine abuse. Elevated 
BDNF expression in the VTA could induce persistent functional activation of the NAc, 
resulting in the accumulation of DeltaFosB. The reduction of BDNF expression in 
prelimbic cortex (PrL) might also contribute to escalating drug-taking behavior, possibly 
through decreased inhibitory output to areas involved in drug reinforcement and 
motivation.      
Introduction  
The propensity to develop compulsive patterns of drug taking varies in humans 
(Warner La, 1995), and the transition from recreational to compulsive drug use depends 
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on the vulnerability of the intrinsic nervous system and can be influenced by 
environmental stimuli, such as stress. Stress is an etiological factor which can increase 
likelihood of drug abuse in vulnerable individuals (Sinha, 2001). Among many stress 
models in laboratory animals, the social defeat stress model has great ethological value 
because it is natural and non-adaptable, and has a high degree of face validity when 
compares to the aversive consequences of peer competition and personal failure in 
humans. Rats exposed to intermittent social defeat stress exhibit facilitated acquisition of 
cocaine self-administration and enhanced motivation to self-administer cocaine (Miczek 
et al., 2004; Miczek & Mutschler, 1996), as well as behavioral sensitization to 
psychostimulants (Miczek, Nikulina, et al., 1999; Nikulina et al., 2004).  
Repeated social defeat stress induces increase of brain-derived neurotrophic factor 
(BDNF) expression in the ventral tegmental area (VTA), a cell body region of 
dopaminergic neurons, which in turn has a potentiating effect on the sensitization to 
psychostimulants (J. Wang et al., 2013). Increased BDNF in the VTA is also associated 
with enhanced drug-seeking behavior that occurs during withdrawal from cocaine self-
administration (Jeffrey W. Grimm et al., 2003). Further, administration of BDNF onto the 
VTA brain slices sensitize dopaminergic neurons to excitatory input (Pu et al., 2006). In 
contrast, heterozygous BDNF knock-out mice exhibit reduced behavioral response to the 
rewarding and psychomotor-activating effect of cocaine (Hall, Drgonova, Goeb, & Uhl, 
2003). Considering the essential role of BDNF in synaptic plasticity (Kang & Schuman, 
1995; Korte et al., 1995), enhanced BDNF in the VTA could induce neuroplasticity in 
mesocorticolimbic circuit leading to enhanced stress-induced vulnerability to drugs of 
abuse.  
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The VTA, nucleus accumbens (NAc), and prefrontal cortex (PFC) are the major 
nodes in the mesocorticolimbic circuit, which is the neural substrate of both drugs of 
abuse and stress (P. W. Kalivas & Stewart, 1991; Wise, 1998). BDNF can be synthesized 
from dopaminergic neurons in the VTA and glutamatergic neurons in the PFC and 
transported antereogradely to the NAc (Altar et al., 1997). Enhanced BDNF signaling in 
the VTA could cause neuroadaptation in these projected areas, and such changes may 
contribute to the increased susceptibility to the rewarding effect of drugs of abuse 
(Bolanos & Nestler, 2004). Previous evidence showed that VTA BDNF overexpression 
alone increases DeltaFosB, a truncated member of the Fos family of transcription factors, 
in both the PFC and NAc (J. Wang et al., 2013). Also increased co-localization of BDNF 
and DeltaFosB was found in the NAc and PFC of rats with elevated VTA BDNF levels 
after exposure to intermittent social defeat stress (Nikulina et al., 2012). DeltaFosB is 
induced in the NAc in response to chronic exposure of numerous drugs of abuse (Nestler, 
2008). Elevation of DeltaFosB in the NAc induces stronger incentive salience attributed 
to cocaine (Colby, Whisler, Steffen, Nestler, & Self, 2003). In addition, overexpression 
of DeltaFosB in dynorphin expressing NAc neurons induces sensitization to cocaine 
(Kelz et al., 1999). Therefore elevated DeltaFosB, especially in the NAc, could be a 
molecular mechanism underlying persistent vulnerability to the addictive effects of 
cocaine found in stressed individuals.  
In the current study, we investigated whether enhanced VTA BDNF signaling 
works as a risk factor inducing higher vulnerability to cocaine abuse and whether VTA 
BDNF can further enhance the potentiating effect of social defeat stress on compulsive 
cocaine taking behavior. To examine our hypotheses, self-administration paradigm was 
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used in which the drug intake during the acquisition, progressive ratio, and 12-h binge 
with unlimited access to cocaine were measured. DeltaFosB, a molecular switch of long-
term addictive state, was also measured in the NAc of these rats. Also BDNF expression 
in the PFC was also measured as an index of reduced inhibitory control of compulsive 
drug use.   
Material and Methods   
Animals 
Male Sprague-Dawley rats weighing 250-300 g were housed individually in a 
temperature-controlled colony room, with water and food available ad libitum, on a 14-h 
reversed light/dark cycle. Animal care and housing conditions were consistent with the 
Guide for Care and Use of Laboratory Animals (National Research Council, 1996). 
Surgical and experimental procedures were approved by the Institutional Animal Care 
and Use Committee at Arizona State University. Rats were acclimated to handling for 7 
days and weighed 310-400 g prior to surgery. 
Surgery 
Rats were administered an analgesic (buprenorphine, 0.05 mg/kg, s.c.) prior to 
induction of isoflurane anesthesia (2-3%; Abbott Laboratories, North Chicago, IL), 
vaporized in oxygen and delivered through a plastic nose cone. Catheters were 
constructed from Silastic tubing (10 cm length, 0.012 in inner diameter, 0.025 in outer 
diameter, Dow Corning, Midland, MI) connected to a 22-gauge nonferrous metal cannula 
encased within a plastic screw connector (Plastics One, Roanoke, VA). A miniature ball 
of aquarium sealant was affixed 2.7 cm from the free end of the catheter. A burrow was 
made subcutaneously from an incision on the neck to an incision across the skull, and the 
 88 
catheter was pulled through the burrow. A small incision was made in the jugular vein, 
where the catheter was inserted and secured with sutures on both sides of the ball.  Then 
Rats were positioned in a stereotaxic frame (David KOPF Instruments; Tujunga, 
California). Two holes were drilled at stereotaxic coordinates (AP −5.1 mm; ML ±2.15 
mm from the bregma) on the surface of skull, and Hamilton syringes (Model 7105 KH; 
Reno, NV) with 24 gauge injector tips were lowered through the holes bilaterally at a 10° 
angle until needle tips reached the VTA (AP −5.1 mm; ML ±0.6 mm; DV −8.8 mm from 
the bregma; Paxinos and Watson, 2007); 0.5 µl of virus was bilaterally infused into each 
side of the VTA for 10 min at a speed of 0.05 µl/min. The microphotograph of the 
infusion site is presented in Figure 18.B. After infusion, the syringes remained in the 
infusion sites for 5 min to prevent retrace of virus. 
After the intracranial viral infusion surgery, the cannula end of the catheter was 
then anchored to the skull using dental acrylic cement and four small anchor screws. The 
head and neck incisions were sutured and treated with a topical antibiotic and the rats 
were administered an anti-inflammatory (meloxicam; 1 mg/kg, s.c.). A flexible obturator 
made from Tygon tubing was fitted over the cannula to protect the catheter. Patency of 
the catheters was maintained throughout the experiment by daily flushing with 0.1 ml 
timentin (66.67 mg/mL; bioWORLD, Dublin, OH) in saline solution containing 70 
units/mL heparin sodium. Catheter patency was tested periodically with 0.8 g 
methohexital sodium (Brevital, Sigma), a dose that produces rapid loss of muscle tone 
only when administered i.v. Following surgery, rats were left to recover for 7 days in 
their home cages and were handled and weighed daily. 
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Intermittent social defeat stress 
One week after the surgery, rats were exposed to intermittent social defeat stress. 
Social defeat stress is consisted of a short exposure to aggressive behavior of a resident 
rat, described in detail previously (Nikulina et al., 2012). Each resident rat (long-evans rat, 
retired breeder) was group housed with one female rat for at least two weeks before 
assigning for social defeat experiment. After removing the female from the resident’s 
cage, the experimental intruder rat was placed into the resident’s home cage under a 
stainless steel mesh protective cage (15×25×15 cm) for the first 5 min. Then the 
protective cage was removed, and the resident displayed aggressive behavior. “Defeat” 
occurred when the intruder exhibited a supine posture for at least 4 s. Aggressive 
interactions were 2–5 min in duration. After the display of supine posture, further 
physical contact was prevented by putting the intruder under the protective cage for an 
additional 15 min before returning to its home cage. There are total 4 times exposure to 
social defeat stress in 10 days. Control rats were handled and weighed on the days their 
counterparts were defeated and weighed.  
Apparatus of self-administration 
One week after the last episode of social defeat stress, rats were put inside the 
self-administration chamber and started to receive training for cocaine self-administration. 
Training and testing were conducted in Plexiglas operant conditioning chambers (20 × 28 
× 20 cm) equipped with a food pellet dispenser and a food well located between two 
retractable levers mounted on the front panel (Med Associates, St. Albans, VT). A 
stimulus light was mounted above one lever, a tone generator (500 Hz, 10 dB above 
background noise) was mounted on the side wall and a house light was mounted on the 
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rear wall opposite the levers. The lever below the stimulus light was designated as the 
active lever. Each conditioning chamber was housed within its own ventilated, sound-
attenuating cabinet. An infusion pump containing a 10-ml syringe was located outside of 
the cabinet. Tygon tubing connected to the syringe was attached to a liquid swivel 
(Instech, Plymouth Meeting, PA) suspended above the operant conditioning chamber. 
The outlet of the swivel was fastened to the catheter via Tygon tubing that ran through a 
metal spring leash (Plastics One). The leash fastened onto the plastic screw of the cannula 
that was anchored on the animal’s head. 
Acquisition and maintenance 
 A timeline of the experiments is presented in Figure 19.A. 
Following recovery from surgery, self-administration (SA) training was 
conducted during daily 2-h sessions that were signaled by the illumination of the stimulus 
light above the active lever. Rats were given the opportunity to self-administer cocaine 
(0.75 mg/kg/0.1 ml, i.v.) on a fixed ratio (FR) 1 schedule of reinforcement. Pressing the 
active lever was reinforced by an infusion followed by a 30-s timeout, during which the 
stimulus light was turned off and responses did not count toward the ratio requirement. 
Responses on the inactive lever were recorded, but did not result in any consequences. 
Each daily session terminated after the delivery of 15 infusions or 5 h of access. After the 
rat self-administered 15 cocaine infusions on 2 consecutive days, the response 
requirement was gradually increased from FR 2 to FR 5 over the next 3-5 days. The rats 
were maintained on a FR 5 schedule (15 infusions per day or 5 h access) for 5 
consecutive days.  
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Progressive ratio 
 For the 6 days following acquisition and maintenance, self-administration 
according to a progressive ratio (PR) schedule of cocaine reinforcement (0.375 
mg/kg/infusion) was studied in each rat every other day, with maintenance sessions 
(0.75mg/kg/infusion, FR 5, 15 infusions) to cocaine on alternating days. The algorithm 
for each successive cocaine infusion was derived from earlier work (Richardson & 
Roberts, 1996). The progression response requirement was as follows: 1, 2, 4, 6, 9, 12, 15, 
20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178… Rats had 1 h to successfully complete each 
ratio requirement. The last completed ratio, corresponding to the final infusion delivered, 
was defined as the breaking point.  
12-h Binge session 
 After the final PR session, each rat was allowed one maintenance session of 
cocaine (0.75 mg/kg/infusion, FR 5, 15 infusions). The very next day, a prolonged access 
protocol was implemented starting at approximately 8:00 a.m. (i.e., 2 h after the start of 
the dark cycle). Each rat was allowed continuous access to cocaine (0.375 mg/kg/infusion, 
FR 5) during the entire 12-h session.  
Reinstatement 
 Following 5 days of abstinence, rats were transported to the operant chambers for 
extinction and reinstatement test sessions conducted over four consecutive phases: (1) 
extinction, (2) cue reinstatement, (3) saline reinstatement, and (4) cocaine reinstatement. 
During extinction, the session was signaled by the illumination of the stimulus light, but 
lever presses had no consequences. After one hour, the cue reinstatement phase began by 
presentation of the stimulus light at the beginning of the session and active lever presses 
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resulted in termination of the light for a 30-s timeout on an FR 1 schedule of 
reinforcement to resemble the response-contingent presentation of the cue during self-
administration training. Two hours later, the saline reinstatement phase began by 
administration of a priming injection of saline (IP) and cues were presented the same as 
during cue reinstatement. Following one hour, the cocaine reinstatement phase began by 
administration of a priming injection of cocaine (10 mg/kg, IP) and cues were presented 
the same as during cue reinstatement for a one hour session. The data of reinstatement is 
not conclusive, therefore not shown.    
Perfusion and tissue processing 
 Ten days after binge session, all rats were deeply anesthetized with sodium 
pentobarbital (100 mg/kg, i.p.) and perfused transcardially with 10 ml of 10% heparin in 
0.1 M phosphate-buffered saline (pH 7.4) followed by 250 ml of 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.4). Brains were post-fixed for 1 h in the same fixative at 
4°C, soaked in 15% sucrose, then in 30% sucrose in 0.1 M PBS at 4°C until saturated, 
then stored at 4°C prior to sectioning.  Brains were sectioned at 20 µm in a cryostat at 
−22°C, and thaw-mounted onto glass slides (Superfrost Plus; Fisher; Waltham, MA). 
Sections were collected from +3.2 to +2.8 mm from bregma for the PFC, +1.8 to +0.8 
mm from bregma for the NAc, and −4.8 to −5.6 mm from bregma for the VTA (Paxinos 
and Watson, 2007).  
Immunohistochemistry 
 Sections were washed in 0.05 M potassium phosphate-buffered saline (KPBS), 
then blocked for 1 h in 10% normal donkey serum and 0.4% Triton X-100 in 0.05 M 
KPBS. Sections were then incubated with primary antibody: BDNF (AB1779SP, 1:3,000 
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dilution; Millipore; Temecula, CA) or FosB (SC-48, 1:5,000 dilution; Santa Cruz 
Biotechnology, Inc.; Santa Cruz, CA). The FosB antibody used here targets the N 
terminal of FosB protein contained in both FosB and DeltaFosB. However, based on the 
timeline of the present research, FosB-like labeling would primarily capture 
accumulation of DeltaFosB because FosB expression is transient and only DeltaFosB 
persists after stimulation (Perrotti et al, 2004). Following incubation with primary 
antibody for 48 h at 4°C, slides were washed in 0.05 M KPBS and incubated for 1 h in 
biotin-conjugated goat anti-rabbit serum (1:200 dilution in blocking solution, Vectastain 
ABC kit; Vector Laboratories; Burlingame, CA). After washing in 0.05 M KPBS, 
sections were incubated with avidin–biotin–peroxidase complex (ABC kit, Vector 
Laboratories) for 1 h, then washed again and developed using DAB chromogen with 
nickel (DAB Peroxidase Substrate kit, Vector Laboratories). After dehydration in graded 
concentrations of ethanol and xylene, coverslips were applied. 
To examine the cellular localization of BDNF expression in the VTA of animals that 
showed persistent cross-sensitization, we performed fluorescent double labeling of BDNF 
and tyrosine hydroxylase (TH). Primary antibodies, rabbit anti-BDNF (AB1779SP, 1:500 
dilution; Millipore; Temecula, CA) and mouse anti-TH (SC-7837, 1:500 dilution, Santa 
Cruz Biotechnology; Santa Cruz, CA), were applied simultaneously and incubated for 48 
h at 4°C. After incubation with biotinylated goat anti-rabbit IgG (1:200 dilution, Vector 
Laboratories) for 1 h, Alexa Fluor 488 Anti-Rabbit conjugated streptavidin and Alexa 
Fluor 548 Goat Anti-Mouse (1:500 dilution, Invitrogen, San Diego, CA) were applied for 
2 h. After washing with 0.05 M KPBS, coverslips were applied with ProLong Gold 
Antifade Reagent with DAPI (Invitrogen, San Diego, CA). Not all samples were 
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processed for fluorescent double labeling, making the sample number different from 
other IHC labeling. For fluorescence double labeling, sample numbers are as follow: n = 
7 for AAV-GFP-handled, n = 13 for AAV-GFP-stressed, n = 8 for AAV-GFP-handled 
and n = 15 for AAV-BDNF-stressed.   
Image analysis 
 Tissue sections were examined for the presence of chromogen or fluorophore 
reaction products using a Zeiss Axioskop microscope; selected areas were captured and 
digitized using a color digital video camera (MBF Biosciences; Williston, VT) or 
AxioCam MR (Zeiss) interfaced to the microscope. A cell profile was considered labeled 
if its pixel intensity was more than 2 standard deviations greater than the background, as 
calculated by Stereo Investigator software (MBF Biosciences). Fluorescent-labeled cells 
were counted manually, first in single channels for single labeling, then in merged 
channels for double labeling. At least three adjacent sections were analyzed for each 
brain region per animal, and labeling density was calculated by dividing the estimated 
total number of labeled profiles by the total area analyzed.   
Statistics 
 Behavioral result of cocaine self-administration and immunohistochemical data 
were analyzed by two-way ANOVA (between subjects factors: viral vector [AAV-BDNF 
vs. AAV-GFP] and behavioral treatment [handling vs. stress]). T-test was used for 
planned comparisons between AAV-BDNF-stressed and all other groups when 
significant interaction was not present, and post-hoc Tukey test was used in the presence 
of significant interaction. All data are reported as mean ± SEM. Results were considered 
significant if p ≤ 0.05. The sample numbers varied slightly across different procedures 
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examining different brain regions due to the exclusion of samples with occasional 
artifacts during tissue collection or processing.  
Results  
BDNF and social defeat alone enhance acquisition of cocaine self-administration 
 To measure acquisition, we calculated the number of infusions an animal obtained 
before they successfully completed an FR1 session (15 infusions/session). We found that 
both the AAV-GFP-stressed(8.16 ± 2.18) and AAV-BDNF-handled (7.09 ± 1.71) groups 
takes fewer cocaine infusions to reach the acquisition criteria compared to GFP-handled 
(13.05 ± 2.24) and BDNF-stressed groups (13.6 ± 2.89), who exhibited similar 
acquisition rates (Figure 20.A). This was evident by a significant interaction between 
virus and stress (F(1, 62) = 5.37, p < 0.05). AAV-BDNF-handled rats takes significantly 
less infusions to acquire stabilized self-administration compared to handled rats received 
control AAV-GFP virus (p = 0.042) and AAV-BDNF-stressed rats (p = 0.041).  
Social defeat enhances motivation for cocaine 
 When compared to handled controls, socially defeated animals exhibited higher 
rates of intake and responding on a progressive ratio (PR) schedule of cocaine 
reinforcement, regardless of virus condition (Figure 20.B and C).  There were significant 
main effects for stress on active lever pressing numbers (F(1, 62) = 6.979, p = 0.010) and 
infusion received (F(1, 62) = 7.989, p = 0.006), but no main effect of virus (ranging from 
F(1, 62) =  0.10 and 0.16, p = 0.69 and 0.75 respectively) nor interaction between the two 
factors (ranging from F(1, 62) =  1.36 and 2.52, p  = 0.12 and 0.25 respectively).  
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VTA BDNF titrates compulsive cocaine taking behavior during 12-h access 
“binge” 
 During the 12-h access to cocaine session, the BDNF-stress group had the highest 
rates of intake and responding, followed by the GFP-stressed, BDNF-handled, and GFP-
handled (Figure 20.D and E). There were significant main effects of stress (F(1, 63) =  
12.731, p = 0.001) and virus (F(1, 63) =  4.344, p = 0.041) for responding.  
 Intra-VTA infusion of AAV-BDNF or intermittent social defeat stress induced 
significant elevation of BDNF expression in the VTA after cocaine self-administration, 
shown by the significant main effects of AAV-BDNF (F (1, 53) = 40.176, p = 0.001) and 
stress (F (1, 53) = 15.377, p = 0.001; Figure 21. A and B) using two-way ANOVA. A 
positive correlation between VTA-BDNF expression levels and drug taking behavior 
during 12 h binge was found (Pearson Correlation: r = 0.422, p = 0.001; Figure 21.C). 
 The number of BDNF expressing dopaminergic neuron in the rostral VTA was 
also increased in rats received AAV-BDNF after cocaine self-administration (F (1, 39) = 
20.006, p = 0.001). However, stress failed to affect the number of BDNF expressing 
dopaminergic neurons in the rostral VTA (F (1, 39) = 0.24, p = 0.627; Figure 22.A and B).   
VTA BDNF overexpression induced compensatory change of BDNF in the 
prelimbic PFC 
 After chronic cocaine self-administration, rats with VTA BDNF overexpression 
showed a significant reduction of BDNF expression levels in the prelimbic cortex (PrL-
PFC) compared to rats received control GFP virus (F (1, 59) = 5.525, p = 0.022). However, 
no effect of intermittent social defeat stress on BDNF expression was observed in PrL-
PFC (F (1, 59) = 1.544, p = 0.217). Such VTA BDNF overexpression induced reduction of 
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PFC BDNF is specific to the PrL-PFC subregion, because no change of BDNF 
expression was found in ACG-PFC (F (1, 56) = 2.889, p = 0.095; Figure 23.A and B).   
Persistent enhanced VTA-BDNF increased DeltaFosB expression in both shell 
and core of the NAc   
 After chronic cocaine SA, VTA BDNF overexpression induced significantly 
increased DeltaFosB expression in both core (F (1, 48) = 8.366, p = 0.006) and shell 
subregions (F (1, 48) = 5.593, p = 0.022) of the NAc in rats, compared to groups received 
GFP virus (Figure 24.A and B). However, the main effect of stress on DeltaFosB 
expression was not significant in core (F (1, 48) = 0.049, p = 0.826) and shell subregions (F 
(1, 48) = 0.146, p = 0.704) of the NAc after chronic cocaine SA.       
Discussion  
The present study showed that higher BDNF level in the VTA can facilitate the 
acquisition of cocaine self-administration and potentiate compulsive drug taking behavior 
during 12-h binge. Our behavioral data also confirmed that repeated social defeat stress 
facilitates acquisition and increases motivation to self-administer cocaine. Stress induced 
escalation of cocaine self-administration during 12-h binge is further augmented by 
enhanced BDNF expression in the VTA. We discovered a positive correlation between 
VTA BDNF expression level and drug taking behavior during 12-h binge. VTA BDNF 
overexpression also induces significant elevation of DeltaFosB in the NAc core and shell 
subregions, and a reduction of BDNF specifically in PrL cortex after chronic cocaine 
self-administration.  
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VTA-BDNF, intermittent social defeat stress-induced escalation of cocaine self-
administration  
Social defeat stress is an etiological factor enhancing the vulnerability to develop 
compulsive drug-taking behavior. Stress can sensitize the brain reward circuit, leading to 
enhanced dopamine transmission onto the NAc in response to drugs of abuse (Tidey & 
Miczek, 1996), which ultimately leads to enhanced sensitivity to rewarding effect of 
drugs of abuse and behavioral sensitization to drugs of abuse. Previous papers 
demonstrated that intermittent social defeat stress facilitates acquisition of cocaine self-
administration (Haney, Maccari, Le Moal, Simon, & Piazza, 1995), increases the 
motivation for cocaine, and enhances the compulsive drug-taking behavior during binge 
with unlimited access to drug (H. E. Covington, 3rd & Miczek, 2001). 
The gradual increase of BDNF in the VTA is one of the hallmark neurochemical 
changes after social defeat stress (Fanous et al., 2010), and the elevation of VTA BDNF 
potentiates psychomotor sensitization to amphetamine (J. Wang et al., 2013). Taken 
together, these data suggest that enhanced BDNF signaling from the VTA after stress 
could engender higher vulnerability to the sensitizing effect of psychostimulants. Drug 
self-administration has great face validity as a model to study neuroadaptation important 
for compulsive drug-taking behavior and the reinforcing efficacy of drugs of abuse. 
Therefore, to examine whether VTA BDNF expression also engenders higher 
vulnerability to the stress-induced rewarding effect of psychostimulants and incentive 
sensitization, we overexpressed BDNF in the VTA using AAV-mediated gene transfer, 
and measured whether such overexpression could enhance drug-taking behavior during 
acquisition, PR and 12-h binge sessions in cocaine self-administration. 
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We found that handled rats with VTA BDNF overexpression initiated cocaine 
self-administration a faster rate than GFP controls in term of reaching our acquisition 
criterion. It is a well-known phenomenon that some people experience compulsive 
craving for cocaine after only a few times of exposure, and such vulnerability can be 
influenced by stress (Tidey & Miczek, 1997). Our data suggest that the enhanced VTA 
BDNF signaling could be another intrinsic risk factor conferring higher vulnerability to 
develop compulsive drug taking behavior. Such facilitation on acquisition could be 
caused by augmented reinforcing effect of cocaine, possibly through BDNF’s 
potentiating effect on the functioning of dopamine neurons located in the VTA (Altar et 
al., 1992; Horger et al., 1999; Martin-Iverson, Todd, & Altar, 1994).  
Interestingly, rats with both stress exposure and VTA BDNF overexpression 
showed blunted acquisition of cocaine self-administration, compared to rats who received 
either stress or VTA BDNF overexpression alone. One possible explanation for the 
facilitation of these two factors by themselves but not together is that both stress and 
VTA BDNF overexpression can enhance arousal, and such arousal can improve or impair 
the performance of learning tasks, depending on the magnitude (Yerkes & Dodson, 1908). 
Arousal improving performance could reduce infusions required to learn the association 
between lever pressing and drug infusion. However, VTA BDNF overexpression may 
confer higher susceptibility to the intermittent social defeat stress, which could produce 
too high of an arousal state that may hamper the performance of an operant learning task 
(i.e., lever pressing). The blunted acquisition found in AAV-BDNF-stressed rats was 
likely not due to reducing the reinforcing effect of cocaine, because these rats exhibited 
no deficit during maintenance once cocaine self-administration was acquired, and 
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consumed the highest amount of cocaine during the 12-h binge session. Therefore 
excessive arousal may underlie the blunted acquisition of cocaine self-administration in 
AAV-BDNF-stressed rats. Further characterization of glucocorticoid levels could shed 
light into the potential impairment of performance and learning induced by stress together 
with VTA BDNF overexpression (Lupien, Maheu, Tu, Fiocco, & Schramek, 2007).  
The break points during PR sessions in social defeat animals was significantly 
higher than handled rats, reflected higher motivational salience assigned to cocaine, 
which is consistent with previous work (H. Covington, III & Miczek, 2005). Of note, 
VTA BDNF overexpression has a potentiating effect on locomotor sensitization (J. Wang 
et al., 2013). However, VTA BDNF overexpression alone had no effect on the 
motivational salience attributed to cocaine. It also appears that stress-induced excessive 
motivational salience attributed to cocaine was slightly attenuated by VTA BDNF 
overexpression. Taken together, our data imply a dissociation between the locomotor and 
incentive sensitization, and that VTA BDNF may have distinct effects on locomotor 
sensitization and incentive sensitization.       
We found that stress induces potent escalation of drug self-administration during 
the binge session, which is consistent with previous findings. Also, elevated VTA BDNF 
expression prior to social defeat stress induced further escalation of cocaine self-
administration during the 12-h binge session, suggesting that enhanced VTA BDNF 
signaling may facilitate the stress induced neuroplasticity in the brain reward circuitry 
which enhances the reinforcing effect of cocaine, ultimately leading to further escalation 
of drug taking.  
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Neurochemical changes in mesocorticolimbic circuitry underlying escalation of 
cocaine self-administration 
 We have recently showed that AAV-mediated BDNF overexpression in the VTA 
increases DeltaFosB expression in both the core and shell subregions of the NAc (Wang 
et al., 2013). DeltaFosB is a truncated variant of the FosB transcription factor. DeltaFosB 
accumulation in the NAc is found after chronic exposure to virtually all kinds of drugs of 
abuse and stress (Nestler, 2008; Perrotti et al., 2004). Increased DeltaFosB in the NAc 
leads to behavioral sensitization to cocaine (Kelz et al., 1999), and increases in cocaine 
reward (Muschamp, Nemeth, Robison, Nestler, & Carlezon Jr, 2012). Although repeated 
social defeat stress-induced DeltaFosB in the NAc can be found at least 10 days after the 
cessation of defeat (Nikulina et al., 2012), we did not find a significant effect of stress on 
DeltaFosB in the NAc after chronic cocaine self-administration in our study. Chronic 
cocaine administration can produce epigenetic changes that increase the transcriptional 
potential of FosB in the NAc, leading to a greater extent of cocaine-induced of DeltaFosB 
expression (Damez-Werno et al., 2012). Therefore, the stress-induced DeltaFosB 
elevation in the NAc could be occluded by the elevation of DeltaFosB during chronic 
cocaine self-administration. Also, increased DeltaFosB expression in the NAc suggests 
persistent functional activation of this region in the presence of enhanced VTA BDNF 
signaling. 
 Human imaging studies have discovered that cocaine addicts exhibit deficits in 
prefrontal cortical function and consequential loss of inhibitory control over drug-taking 
behavior (Goldstein & Volkow, 2002). The prelimbic (PrL) cortex sends robust 
projections to the NAc core, and BDNF from PrL cortex is anterogradely transported to 
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terminals in the NAc (Altar et al., 1997), providing regulation onto the mesolimbic 
reward circuit (Vertes, 2004). Enhanced BDNF signaling in the PrL cortex leads to 
decreased cocaine-seeking in rats (Berglind et al., 2007), suggesting that enhanced BDNF 
signaling in this area acts to inhibit drug seeking. In contrast, a marked reduction of 
neural activity in PrL cortex was found after extended cocaine self-administration, and 
such this reduction was greater in rats exhibiting compulsive drug seeking (B. T. Chen et 
al., 2013). We observed a reduction of BDNF specifically in the PrL cortex of rats 
receiving VTA BDNF overexpression, and such a reduction of BDNF in PrL cortex may 
contribute to the escalation of cocaine self-administration and increased susceptibility to 
stress-induced vulnerability to drug. However, the mechanism underlying VTA BDNF 
overexpression-induced reduction of PrL BDNF in rats exposed to chronic cocaine self-
administration is unknown and warrants investigation.  
Conclusion  
In the present study, we found that VTA BDNF overexpression reduces the 
number of reinforcers administered before reaching acquisition criteria, suggesting that 
individuals with higher VTA BDNF may have greater sensitivity to the reinforcing 
effects of psychostimulants, such as cocaine, and be more vulnerable to transitioning to 
compulsive drug use. We also discovered a graded escalation of compulsive cocaine use 
during the 12-h binge which positively correlates with the BDNF expression in the VTA 
across treatment groups, suggested a gene-behavioral response relationship. Also, VTA 
BDNF overexpression induces significantly elevated DeltaFosB expression in both the 
core and shell regions of the NAc after chronic cocaine self-administration, an enduring 
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transcription factor known to induce higher sensitivity to the rewarding effect of 
psychostimulants (Grueter et al., 2013; Kelz et al., 1999).  
Our result suggests that enhanced BDNF in the VTA may represent an intrinsic 
mechanism conferring individuals more susceptible to the stress-induced vulnerability to 
drugs of abuse. Therefore, increases of BDNF in the VTA may be a risk a factor inducing 
higher vulnerability to develop psychostimulant dependence, especially under stressful 
conditions.      
Chapter 5  
GENERAL CONCLUSION AND FUTURE DIRECTIONS 
Summary of Key Findings 
 The objective of the current study is to investigate the role of mesolimbic BDNF 
signaling as a potential risk factor underlying stress induced vulnerability to 
psychostimulants. Therefore, we used the social defeat stress model, which has face 
validity in replicating interpersonal conflict and peer pressure in humans, and examined 
whether AAV-mediated intra-VTA BDNF overexpression would potentiate social defeat 
stress induced cross-sensitization to psychostimulants and escalation of compulsive drug 
taking. We also studied the neurochemical changes in the major nodes of the 
mesocorticolimbic circuit induced by social defeat stress in the presence of enhanced 
VTA BDNF. 
 In chapter 2, the effects of VTA BDNF on single social defeat-induced cross-
sensitization and on a non-sensitizing dosing regimen of AMPH-induced locomotor 
response were investigated. We found that enhanced VTA BDNF prolongs the time-
course of single social defeat stress induced cross-sensitization and potentiates the 
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locomotor response to a non-sensitizing dosing regimen of AMPH. In particular, we 
found that VTA BDNF overexpression alone leads to increased DeltaFosB accumulation 
in the projection areas of the VTA: the PFC and NAc. Also persistent elevation of BDNF 
in dopaminergic neurons across the entire rostral VTA was observed in rats receiving 
both VTA BDNF overexpression and single social defeat stress. Of note, the highest 
magnitude of elevation of DeltaFosB was found in the NAc shell subregion of rats 
exposed to social defeat stress which received intra-VTA BDNF overexpression. 
Therefore, we hypothesized that BDNF signaling in the NAc shell is critical for induction 
of the neuroplasticity underlying social defeat stress induced cross-sensitization. In 
chapter 3, we further examined this hypothesis.  
 In chapter 3, TrkB receptor knockdown in the NAc shell was found to prevent 
intermittent social defeat stress-induced cross-sensitization to AMPH, which confirmed 
our hypothesis. We also examined several important neurochemical up-regulations 
induced by intermittent social defeat stress which are also related to BDNF signaling in 
the mesolimbic circuit. We discovered that intermittent social defeat stress-induced 
increase of BDNF and GluA1 in the VTA were prevented by TrkB knockdown in the 
NAc. The level of phospho-ERK, the activated form of a downstream effector of BDNF-
TrkB signaling cascade, was significantly reduced by NAc-TrkB knockdown, whereas 
total level of ERK remained unaffected by TrkB knockdown. Also intermittent social 
defeat stress induced DeltaFosB accumulation in the NAc was prevented by intra-NAc 
TrkB knockdown. A schematic representation of these neurochemical changes induced 
by TrkB knockdown in stressed animals can be seen in Figure 25. So far, we examined 
the role of mesolimbic BDNF on stress-induced augmentation of locomotor response to 
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AMPH. However, locomotor sensitization cannot recapitulate several important aspects 
of addictive behaviors, such as motivation and reinforcing effect. In contrast, the self-
administration model, which can measure incentive sensitization, has greater face validity 
as a model for motivational changes underlying compulsive drug seeking in addicts. 
Therefore, we used a cocaine self-administration model to further study VTA BDNF’s 
role during stress induced vulnerability to psychostimulants.   
 In chapter 4, the role of enhanced VTA-BDNF on stress-induced vulnerability to 
develop compulsive drug taking behaviors was examined using a cocaine self-
administration model. With VTA BDNF overexpression and intermittent social defeat 
stress, we measured the susceptibility to initiate cocaine self-administration during the 
acquisition session, the motivational salience attributed to cocaine during PR, and the 
reinforcing properties of cocaine during a 12-h binge, during which unlimited access to 
cocaine was given. We discovered that VTA BDNF overexpression alone facilitates 
acquisition of cocaine self-administration. Also compulsive drug taking behavior during a 
binge session is positively correlated with BDNF expression level in the VTA. 
Interestingly, rats with VTA BDNF overexpression which are also exposed to 
intermittent social defeat stress showed blunted acquisition compared to their 
counterparts receiving either one of these two manipulations alone. Stress increases the 
motivation to take cocaine, observed during a PR sessions. However, VTA BDNF 
overexpression does not induce further increase in incentive salience toward cocaine. 
AAV-mediated BDNF overexpression in the VTA leads to a higher level of DeltaFosB in 
both shell and core subregions of the NAc and lower level of BDNF in PrL cortex than in 
rats receiving control AAV-GFP virus. These data suggest that the NAc is the region 
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responsive to enhanced BDNF signaling from the VTA, and reduction of BDNF from the 
PrL cortex may contribute to the compulsive drug taking behavior.    
Mechanisms of BDNF Underlying Potentiation of Dopamine Transmission in the 
Mesolimbic Circuit 
 BDNF was first characterized as a nerve growth factor which can enhance the 
survival and activity of dopaminergic neurons (C. Hyman et al., 1991). BDNF activates 
the TrkB receptor–protein tyrosine kinase as the primary means of signal transduction, 
and mRNA for both BDNF and TrkB are expressed in dopaminergic neurons cell body 
regions and terminal fields (Ip et al., 1992). BDNF can enhance the activity of 
dopaminergic neuron and can facilitate the synthesis and the metabolism of dopamine 
(Martin-Iverson et al., 1994; Shen, Altar, & Chiodo, 1994). Therefore, enhanced BDNF 
signaling in the VTA could potentiate the activity of DA neurons and enhance dopamine 
transmission. In the mesolimbic DA system, BDNF synthesized in VTA DA neurons can 
be anterogradely transported to the projection areas, such as the NAc and other forebrain 
structures, such as the PFC and the amygdala (Altar et al., 1997).   
Besides direct potentiation of dopamine neuron activity, BDNF also can enhance 
the sensitivity of DA neurons to excitatory input, therefore increases the excitability of 
DA neurons, ultimately leading to enhanced dopamine transmission in response to neural 
activation. BDNF can up-regulate expression of all four subunits of AMPAR, also can 
induce the assembly of GluA1-containing calcium-permeable AMPAR onto the 
membrane (Fortin et al., 2012). The insertion of calcium-permeable AMPAR onto the 
membrane will facilitate long-term potentiation, and increase membrane conductance and 
synaptic neurotransmission. Also BDNF signaling in the VTA can increase the sensitivity 
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of VTA DA neurons to excitatory signaling input, which is NMDAR-dependent (Pu et al., 
2006). Therefore, BDNF can potentiate the response of VTA DA neurons to excitatory 
input, such as glutamate released from prefrontal sources, leading to enhanced dopamine 
release from VTA DA neurons.  
There is also evidence suggesting that BDNF can suppress the inhibition from the 
GABAergic neurons in several regions of mesocorticolimbic circuit. In the mPFC, 
enhanced BDNF signaling induces down-regulation of the surface level of GABAA 
receptors in mPFC pyramidal neurons, therefore enhances activity-induced long-term 
potentiation (LTP) of excitatory synapses in postsynaptic mPFC neurons (H. Lu, Cheng, 
Lim, Khoshnevisrad, & Poo, 2010). Such effect will lead to the disinhibition of mPFC 
glutamatergic neurons from GABAergic inhibitory control, ultimately leading to greater 
excitatory output to VTA DA neurons.  
BDNF, stress, and vulnerability to drugs of abuse: Implications from our studies 
 Elevation of BDNF in the VTA is observed in stressed animals associated with 
persistent cross-sensitization to psychostimulants, and overexpression of BDNF in the 
VTA can potentiate locomotor sensitization to psychostimulant in stressed animals. 
However, intra-VTA BDNF overexpression alone does not induce significant 
augmentation of locomotor response to psychostimulants. These data suggest that BDNF 
signaling from the VTA acts as a risk factor conferring higher susceptibility to the 
sensitizing effect induced by stress, rather than directly potentiating sensitization to 
psychostimulant.   
 In our studies, besides psychomotor sensitization (or behavioral sensitization), we 
also examined incentive sensitization (motivation to take drug). Our behavioral data show 
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that stress potentiates locomotor response to psychostimulant and induces escalation of 
drug taking during self-administration, which were consistent with previous studies (H. 
Covington, III & Miczek, 2005; Nikulina et al., 2004; Yap & Miczek, 2007). Importantly, 
BDNF can potentiate stress induced psychomotor sensitization, but has no effect on stress 
induced incentive sensitization. These data suggest that BDNF may not be involved in 
stress induced changes of incentive salience toward drugs of abuse.    
In chapter 3 we further demonstrated that depletion of BDNF-TrkB signaling in 
the NAc shell prevented social defeat stress induced cross-sensitization and BDNF 
elevation in the VTA. This result suggests the importance of BDNF signaling in the 
mesolimbic circuit during stress-induced cross-sensitization to AMPH. Based on previous 
data, elevation of BDNF was not observed immediately after repeated social defeat stress, 
but became significant several weeks after social defeat stress. Our data suggest that the 
increase of BDNF in the VTA is not the immediate consequence of social defeat stress, 
and it is possible that the BDNF-TrkB signaling mediated neuroadaptation initiates and 
mediates the gradual increase of BDNF in the VTA, which ultimately leads to higher 
locomotor response to psychostimulants.  
As shown from previous studies, stress sensitizes brain reward circuit and 
generates greater dopaminergic response to psychostimulants (Tidey & Miczek, 1996), 
which could be one of the molecular mechanisms underlying stress induced vulnerability 
to drugs of abuse. Considering the role of BDNF in the survival and activity of 
dopaminergic neurons (Altar et al., 1992; Shen et al., 1994; Siuciak, Boylan, Fritsche, 
Altar, & Lindsay, 1996), persistently enhanced VTA BDNF signaling leads to augmented 
dopamine transmission in the mesolimbic circuit, and therefore potentiates the effect of 
 109 
stress on dopamine transmission in the mesolimbic circuit. Whether stress-induced 
enhancement in mesolimbic dopamine transmission is potentiated in the presence of 
enhanced VTA BDNF requires further investigation.    
 We further measured the factors in different niches of the intracellular signaling 
pathway which are found to be involved in sensitization to drugs of abuse, including 
certain receptor subunits, kinases, and transcription factors. Among these factors 
examined, we found that stress induced DeltaFosB accumulation in the NAc can be 
further augmented by VTA BDNF overexpression; simultaneously it can be prevented by 
the attenuation of BDNF-TrkB signaling in the NAc. These data suggest that DeltaFosB 
in the NAc could be regulated by the VTA BDNF signaling cascades. Considering the 
link between DeltaFosB and addictive behaviors, DeltaFosB could be the effector 
mediating the long-lasting sensitizing effect of drugs of abuse in stressed animals. 
However, the molecular mechanism underlying such regulation remains unknown, and 
requires further investigation.  
Clinical Impilications of BDNF in Relapse Diagonosis, Susceptibility to Addiction 
and Conclusions 
As discussed in chapter 1, the BDNF Val66Met polymorphism has been 
associated with increased vulnerability to develop substance abuse, psychiatric disorders 
and mood disorders in humans. 66Val allele carriers showed comparatively higher 
activity-induced BDNF release in the CNS than 66Met allele carriers, whose activity-
induced BDNF release in the CNS is impaired. A higher frequency of BDNF 66Val 
homozygosity was found in population of addicts, compared with normal control subjects 
(S. J. Tsai, 2007). Also, AMPH induces more pronounced self-ratings of arousal and 
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energy in BDNF 66Val homozygotes than in people with BDNF Met/Val and Met/Met 
genotypes (Flanagin et al., 2006). Although the alterations in BDNF signaling caused by 
BDNF Val66Met polymorphism is different from viral vector-mediated region specific 
BDNF overexpression used in the current study, data from both fields suggested that 
heightened BDNF signaling contributes to the susceptibility to drug addiction. 
Since BDNF can cross the blood–brain barrier in both directions (Pan, Banks, 
Fasold, Bluth, & Kastin, 1998), BDNF is also found in serum and plasma of human blood 
(Radka, Hoist, Fritsche, & Altar, 1996), and serum BDNF level is positively correlated 
with brain BDNF level (Karege, Schwald, & Cisse, 2002). Chronic cocaine use decreased 
serum BDNF, but during the abstinence the serum BDNF level increased significantly, 
and this level was positively correlated with craving (Corominas-Roso et al., 2012; D'Sa, 
Fox, Hong, Dileone, & Sinha, 2011). Therefore, serum levels of BDNF have predictive 
value for the loss of control measure of craving, and can be used as a biomarker for 
relapse. Interestingly, the gradual increase of BDNF levels in the serum during early 
abstinence is coincident with the elevation of BDNF in several regions of 
mesocorticolimbic circuit during “craving incubation” (Jeffrey W. Grimm et al., 2003).  
The current studies discovered that enhanced VTA BDNF expression potentiates 
stress induced cross-sensitization to AMPH and escalates compulsive cocaine taking 
behavior, implicating that elevated VTA BDNF signaling acts as a risk factor in stressed 
individuals conferring higher stress induced vulnerability to drugs of abuse. Also based 
on the data in chapter 3, TrkB in the NAc shell could be a therapeutic target, and 
medication which inhibit TrkB activation in the NAc could prevent sensitized response to 
psychostimulant developed in stressed individuals.  
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Table 1  
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2
















419.4 ± 50.1 
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Figure 1. Opponent process model of addiction. According to the opponent process 
theory the affective (hedonic or emotional) response to a drug is the underlying a-process, 
which in turn elicits the opponent b-process. These two underlying processes add 
together to cause the pleasant A-state followed by an opponent unpleasant B-state. 
Initially the pleasant A-state is large, followed by a small B-state. With repeated drug use 
and in addiction, however, the opponent b-process increases in magnitude and duration, 
leading to an experience dominated by the unpleasant symptoms associated with 



























Figure 2. The mesocorticolimbic dopamine system as target of addictive drugs. The 
projection neurons in the VTA are mostly dopaminergic and under inhibitory control of 
local GABA neurons. Nicotine can directly depolarize DA neurons, while opioids, GHB, 
benzodiazepines, and cannabinoids act indirectly via pre- and postsynaptic inhibition of 
GABAergic interneurons (i.e., disinhibition). Cocaine, amphetamines, and ecstasy target 
the dopamine transporter (DAT) on axon terminals and dendrites of DA neurons. While 
cocaine acts as an inhibitor of the DAT, amphetamines and ecstasy promote nonvesicular 
release. In both cases, DA levels in the VTA, NAc, and PFC increase. Image adapted 
























Figure 3. Plasma corticosterone levels of adult male Wistar rats to different stimuli.  
Each test consisted of a standardized series of baseline samples, collected in home cage, 
and a 15min exposure to the stimulus followed by a recovery phase for the remaining 
hour. Blood samples were collected via a jugular vein cannula (Koolhaas, De Boer, De 

















Figure 4. Brain-derived neurotrophic factor (BDNF)-Tropomyosin-related kinase B 
(TrkB) signaling pathways. Phosphorylation of tyrosine 515 of TrkB leads to recruitment 
of the Src homology 2 domain containing (Shc) adaptor protein, followed by recruitment 
of growth factor receptor-bound protein 2 (Grb2) and son of sevenless (SOS) and 
activation of the Ras–MAPK pathway (right). Shc–Grb2 can also lead to recruitment of 
Grb2-associated binder-1 (GAB1) and activation of the PI3K–Akt pathway (left). 
Phosphorylation of the TrkB tyrosine residue 816 results in recruitment of PLC gamma, 
which leads to the formation of inositol triphosphate (IP3) and regulation of intracellular 
Ca2+ and diacylglycerol (DAG),which activates CAMK and protein kinase C (PKC). 
Abbreviations: ERK, extracellular signal regulated kinase; MEK, MAP/ERK kinase; 
MKP1, MAP kinase phosphatase 1; PDK1, 3-phosphoinositide-dependent protein kinase 
1; PTEN, phosphatase and tensin homolog. Image adapted from Duman and Voleti, 2012 

























Figure 5. Alternative splicing of FosB RNA. DeltafosB is generated by a 140 nucleotide 
excision of intron in the open reading frame of full length fosB. This splice event results 
in a one nucleotide frameshift which creates a stop codon (TGA), therefore leads to the 
































Figure 6. Biochemical basis of DeltaFosB’s unique stability. DeltaFosB lacks the C-
terminal 101 amino acids sequence, which contains two degrons domains targeted by 
ubiquitin-mediated degradation (Carle et al, 2007). DeltaFosB can be phosphorylated at 
the N-terminus by casein kinase 2 or other unknown kinases, conferring extra stability 



























Figure 7. Representative photomicrograph of DeltaFosB and BDNF single and 
DeltaFosB/BDNF labeling in NAc Shell, after intermittent social defeat stress. DeltaFosB 
profiles are represented by a dark gray nuclear label, and BDNF cells are labeled with a 
diffuse, purple cytoplasmic stain with an empty nucleus; DeltaFosB/BDNF cells contain 
a dark nuclear DeltaFosB label surrounded by diffusely labeled purple cytoplasm. Black 
arrow: DeltaFosB; red arrow: BDNF; blue arrow: DeltaFosB/BDNF double-labeling. 





















Figure 8. Schematic of experimental design. A. Experiment 1: Time-course of single 
social defeat stress-induced cross-sensitization to AMPH. B. Experiment 2: Effect of 
VTA BDNF overexpression on molecular alterations in mesocorticolimbic areas. C. 
Experiment 3: Effect of single social defeat stress and VTA BDNF overexpression on 















Figure 9. Cross-sensitization to AMPH after a single episode of social defeat stress Is 
observed three days, but not fourteen days after stress. Rats were exposed to a single 
episode of social defeat stress or handling, and then challenged with AMPH (1.0 mg/kg, 
i.p) 3 days or 14 days later. Distance traveled was measured before and after saline 
injection, and following AMPH (1.0 mg/kg, i.p.) challenge. Injection times are indicated 
by vertical arrows. A. Locomotor activity in response to AMPH challenge 3 days after 
single social defeat stress (* p ≤ 0.05). B. Locomotor activity in response to AMPH 




















Figure 10. AAV-BDNF infusion into the VTA produces persistent overexpression of 
BDNF.  A. Brain atlas and representative image of AAV-GFP infusion site (arrow) in the 
VTA visualized by GFP fluorescence, scale bar = 200 µm; VTA: ventral tegmental area, 
fr: fasciculus retroflexus, SN:  substantia nigra. B. Representative photomicrographs of 
BDNF labeling 45 days after AAV-BDNF infusion. Scale bar = 100 µm.  BDNF 
expression near the infusion site is significantly increased after AAV-BDNF; solid arrow 
– BDNF- labeled neurons. C. Number of BDNF labeled cells at infusion site, normalized 
to AAV-GFP control, 14 and 45 days after infusion. D. Number BDNF labeled cells at 
infusion site 45 days after infusion, in AAV-GFP and AAV-BDNF rats. * p ≤ 0.05 















Figure 11. Persistent elevation of VTA BDNF leads to DeltaFosB accumulation in the 
PFC and NAc. A. DeltaFosB expression in the anterior cingulate (ACG), prelimbic (PrL), 
and infralimbic (IL) regions of the PFC. B. AAV-BDNF infusion significantly increased 
DeltaFosB expression in the NAc core and shell.  * p ≤ 0.05 compared with AAV-GFP-
saline rats. C. Representative photomicrographs of DeltaFosB labeling in the PFC (ACG, 
PrL, IL areas) and NAc (core and shell) of AAV-GFP-saline and AAV-BDNF-saline rats; 



















Figure 12. AAV-mediated VTA BDNF overexpression extends the time-course of 
AMPH cross-Sensitization after a single social defeat stress and facilitates drug 
sensitization after repeated AMPH. Locomotor activity (distance in cm) over time (left) 
before and after saline, and following AMPH (1.0 mg/kg, i.p.) challenge (* p ≤ 0.05 
compared to all other groups, †: p ≤ 0.05 compared to the first AMPH injection). 
Injection times are indicated by vertical arrows; response to AMPH (total distance 
traveled in cm) during the peak activity period 10 – 50 min after drug challenge. A. 
Locomotor activity in response to the first AMPH challenge (14 days after stress or 
handling). B. Locomotor activity in response to the second AMPH challenge (24 days 
after stress or handling). C. Interaction plot of locomotor activity during the peak activity 















Figure 13. The number of BDNF expressed neurons increases in whole rostral VTA after 
combined VTA BDNF overexpression, single social stress and repeated AMPH.  
A. BDNF expression  in whole rostral VTA, 45 days after viral infusion, with 
stress/handling procedure and two times AMPH challenges (*p ≤ 0.05 compared to all 
other groups), labeled with fluorophore-conjugated secondary antibodies. B. BDNF/TH 
double labeling in VTA 45 days after viral infusion, with stress/handling procedure and 
two times AMPH challenges. C. Representative microphotographs of fluorescent BDNF 
labeling (left), TH labeling (center), and BDNF/TH double-labeling (right); scale bar = 



























Figure 14. DeltaFosB expression in the NAc shell increases only in response to combined 
VTA BDNF overexpression, single social stress and repeated AMPH. A. Number of 
DeltaFosB-labeled cells in the NAc shell across groups (*p ≤ 0.05 compared to all other 
groups). B. Representative photomicrographs of DeltaFosB labeling in the NAc shell of 



























Figure 15. Validation of AAV-shTrkB-mediated TrkB knockdown in the NAc Shell. 
A. Time-course of viral efficacy validation: 35 days after AAV-GFP/shTrkB viral 
infusion, tissue was collected for validation of TrkB knockdown in the NAc shell. B. 
Brain atlas of the NAc (left), solid circle: infusion site. C. Representative of TrkB 
labeling in the NAc shell of rats received AAV-GFP (left panel) and AAV-shTrkB (right 
panel) (scale bar = 50 µm). D. Number of TrkB-labeled cells in the NAc shell of rats 





















Figure 16. TrkB knockdown prevented repeated social defeat stress-induced cross-
sensitization to AMPH. A. Time-course of AAV-GFP/shTrkB viral infusion and repeated 
social defeat stress-induced cross-sensitization to AMPH. B. Locomotor activity 
(distance in cm) over time before and after saline, and following AMPH challenge (n = 7 
per group). Injections indicated by vertical arrows; C. Locomotor response to AMPH 
(total distance traveled in cm) from 10 to 50 min after drug challenge (* p ≤ 0.05 




























Figure 17. Total ERK1/2 and phospho-ERK1/2 levels in the NAc. A. No difference in 
total ERK1/2 expression levels in the NAc was found across all groups. B. TrkB 
knockdown in the NAc shell caused significant reduction of levels of phospho-ERK1/2 in 
the NAc (n = 7 per group, * p ≤ 0.05 compared to all other groups). Representative bands 













Figure 18. TrkB knockdown in the NAc shell prevented intermittent social defeat stress- 
induced neurochemical changes in the mesolimbic dopamine circuit. Social defeat stress-
induced increase of the BDNF (A) and GluR1 expression in the VTA (B), and the 
DeltaFosB expression in the NAc (C) were prevented by TrkB knockdown in the NAc 
shell (n = 7 per group, * p ≤ 0.05 compared to all other groups). Representative bands of 

























Figure 19. Schematic of experimental design and the viral infusion site. A. Time-course 
of social defeat stress and cocaine self-administration. B. Brain atlas of the VTA, and 
representative image of AAV-GFP infusion site (arrow) in the VTA visualized by GFP 







Figure 20. Behavioral results during acquisition, progressive ratio and twelve-hour binge 
sessions.  A. The number of cocaine reinforcements (0.75 mg/kg/ infusion, i.v.) taken to 
meet our criterion of stabilized self-administration under FR1 ratio. B. The average break 
point for cocaine reinforcements (0.375 mg/kg/ infusion, i.v.) and C) number of active 
lever pressing during the progressive ratio schedule. The y-axis indicates the average 
infusion received (B) and number of active lever pressing (C) across three PR sessions 
for all groups. D. Total number of cocaine infusions (0.375 mg/kg per infusion, i.v.) and 
E) total number of active lever pressing during 12-h binge. Error bars indicate ±SEM. * p 



























Figure 21. BDNF expression in the VTA and correlation with drug taking behavior 
during twelve-hour binge sessions. A. Representative photomicrographs of BDNF 
labeling in the VTA of each group; scale bar = 100 µm. B. Number of BDNF-labeled 
cells in the VTA across groups. Error bars indicate ±SEM. * p < 0.05 compared to AAV-
GFP-handled groups; ** p < 0.05 compared to all other groups. C. Scatter plot for the 
correlation between VTA BDNF expression and the number of active lever pressing 
during 12-h binge. The y-axis indicates the total number of active lever pressing during 
12-h binge session for all rats, and the x-axis indicates the corresponding number of 






Figure 22. The number of BDNF expressing dopaminergic neurons increases in the VTA 
after cocaine self-administration in rats with VTA BDNF overexpression. A. 
Representative microphotographs of fluorescent BDNF labeling (left upper), TH labeling 
(left bottom), and BDNF/TH double-labeling (right); scale bar = 50 µm; filled arrow: 
BDNF and TH double-labeled cell; open arrow: non-dopaminergic BDNF-labeled cell. B. 
BDNF/TH double labeling in VTA after chronic cocaine self-administration (* p ≤ 0.05 
compared to all groups received AAV-GFP control virus), labeled with fluorophore-




























Figure 23. VTA BDNF overexpression reduces the number of BDNF expressing neurons 
in the prelimbic Cortex, but not in anterior cingulate cortex. A. BDNF expression in PrL 
cortex; B. BDNF expression in ACG cortex (*p ≤ 0.05 compared to groups received 



























Figure 24. DeltaFosB expression in the NAc increases in response to VTA BDNF 
overexpression after chronic cocaine self-administration. A. Representative 
photomicrographs of DeltaFosB labeling in the NAc of each group; scale bar = 100 µm. 
B. Number of DeltaFosB-labeled cells in the NAc shell and C) core across groups (*p ≤ 



























Figure 25. Schematic of social defeat-induced neurochemical changes altered by intra-
NAc TrkB knockdown. A. In the NAc, after intermittent social defeat stress, increased 
DeltaFosB was observed. B. TrkB in the NAc prevented stress induced increase of 
DeltaFosB in this area, and reduced the level phospho-ERK, but not total ERK 
expression level in the NAc. C. Intermittent social defeat stress increased the expression 
of BDNF and GluA1 in the VTA. D. TrkB knock-down in the NAc prevented stress 
induced elevation of BDNF and GluA1 in the VTA. Hand drawing by J.Wang.  
 
 
 
 
 
 
 
 
 
 
 
